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Abstract 
Aim 
To investigate the microbial diversity of primary and secondary root canal 
infections using high throughput sequencing on the illumina MiSeq and culture 
methods. 
Methods 
19 subjects were recruited for the study; ten primary infections and nine 
secondary infections. Samples were collected before chemo-mechanical 
preparation (S1) and prior to obturation (S2), respectively. Microbiological 
culture aliquots were serially diluted and inoculated onto various non selective 
and selective media for total anaerobic and total aerobic counts. For high 
throughput sequencing, DNA was extracted and the V3/V4 region of the 
16SrRNA gene was amplified using the 347F/803R primers, sequenced using 
the Illumina MiSeq instrument. Raw data were analysed using an open-source 
bioinformatics pipeline called quantitative insights into microbial ecology 
(QIIME).  
Results  
Culture: Total anaerobic counts from primary infections ranged from 1.7 X101- 
7.9 X106 colony forming units (cfu)/ml (mean log10 cfu/ml ± SD: 3.08 ± 1.51), 
whilst total aerobic counts ranged from 3 X103- 4.17 X105 cfu/ml ( mean log10 
cfu/ml ± SD:3.09 ± 1.72). The quantity of microorganisms recovered from 
secondary infections ranged from 3 X102- 4.9 X103  cfu/ml (mean log10 cfu/ml ± 
SD: 2.81 ± 0.78) and from 2.7 X102- 8 X105 (mean log10 cfu/ml ± SD: 2.60 ± 
1.48) with regard to total anaerobic and total aerobic viable counts, 
respectively.  
Sequencing analysis yielded partial 16S rRNA gene sequences that were 
taxonomically classified into 10 phyla and 143 genera. The most represented 
phyla in the total sample were Firmicutes, Proteobacteria, Actinobacteria, 
Bacteroidetes, Synergistetes and Fusobacteria.  
The most dominant genera in primary S1 samples were Streptococcus, 
Bacillaceae and Eubacterium while Alkalibacterium, Bacillaceae and TG5 
dominated the secondary infections. The majority of genera occurred at low 
levels. The mean number (± SD) of species-level phylotypes per canal was 63           
(±14.9; range 34– 80), and 69.9 (± 12.0; range 50 – 87) in primary and 
secondary infections (S1) samples, respectively. A great inter-individual 
variation in the composition of the root canal microbiota was observed. 
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Conclusions 
The study demonstrated the extensive diversity of the bacterial communities 
present in root canal infections although the majority of the taxa detected were 
in low abundance. The study indicates that secondary infections seem more 
diverse than previously anticipated. 
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Chapter 1 Introduction 
 Justification of the study 
 
The human body contains up to 100 trillion organisms, which approximately 
equates to ten times the number of our own human cells (Di Bella et al., 2013).  
This collection of microorganisms makes up the human microbiome. The oral 
microbiota represents a major component of human microbiome which has an 
important role in human health and disease (Xu and Gunsolley, 2014).  
Oral diseases, such as periodontal disease and dental caries, are some of the 
most common infectious diseases of humans. For example, It is reported that 
up to 90% of the population are affected by periodontal disease (Xu and 
Gunsolley, 2014). 
The oral microbiome is not only associated with inflammation in the oral cavity 
but also with multiple systemic diseases (Hajishengallis et al., 2012), such as 
infective endocarditis (Xu et al., 2007), diabetes (Moodley et al., 2013) and 
colon cancer (Castellarin et al., 2012). 
Apical periodontitis is an inflammatory disorder of the periapical  tissue (Nair, 
2006). The primary cause of apical periodontitis is microbial infection of the 
dental pulp (Kakehashi et al., 1965). Apical periodontitis is a very common 
disease with a prevalence of 30 -80% in different populations and generally 
increasing with age (Chen et al., 2007; Figdor and Gulabivala, 2011).  
The acute form of apical disease is usually localised intraorally but occasionally 
the abscess may spread and result in severe complications or even mortality 
(Siqueira and Rôças, 2013). Chronic apical periodontitis, however, is 
associated with mild or even no symptoms but it can at any point progress to 
an acute form such as acute apical abscess. Systemic consequences of apical 
periodontitis have been suggested but there is no strong evidence (van der 
Waal et al., 2015). 
When the dental pulp becomes infected, endodontic therapy is usually 
indicated if the tooth is to be saved. The primary goal of endodontic treatment 
is the elimination of infection as well as prevention of future re-infection 
(Sjogren et al., 1997). This is traditionally achieved through mechanical and 
chemical means followed by an adequate seal of the root canal and tooth. 
When the tooth becomes infected for the first time, it is commonly referred to as 
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primary infection. Whilst if the tooth had been treated previously but the 
infection persisted or reoccurred, it is known as secondary, persistent or post-
treatment infection. Failure of endodontic therapy has been attributed to several 
factors (Siqueira, 2001) but again the primary cause remains the persistence, 
or re-entry, of microorganisms in the root canal (Sjogren et al., 1997; Siqueira, 
2001).  
The success rates of root canal treatment can reach over 90% but there is wide 
range and it can be as low as 30% (Friedman and Mor, 2004). An 
epidemiological study reported that the success rate of root canal treatment 
performed by endodontists is 87% compared to 72% for treatment carried out 
by general dental practitioners. Although seemingly high, this 15% difference 
equates to many millions of failed treatment in the western population. In the 
US, for example, about 5.1million primary endodontic infections are treated 
every year (Hsiao et al., 2012).  
The last decades have witnessed huge advances in endodontics technology. 
The list include Cone beam CT and Dental operating microscope, flexible 
titanium instruments, rotary files, apex locators, irrigation delivery devices. 
These advances have improved our diagnostics skills, allowed us to manage 
more difficult cases and reduced treatment time. However, the reported 
success rates for root canal treatment has not been in line with these 
developments. A review article argued that the strong emphasis on developing 
technological aids in endodontics has perhaps detracted our attention from the 
primary problem of endodontic disease (Bergenholtz and Spangberg, 2004). 
Our knowledge of endodontic microbiology is evolving but there are several 
unresolved and/or controversial issues, for example the composition and 
behaviour of the root canal microbiota (Siqueira and Rocas, 2005b). Therefore, 
it is clear that in order to enhance our chances of improving root canal 
treatment success, further research to increase our understanding of the 
diversity and ecology of endodontic microbiology is required. 
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 Background 
1.2.1 The dental pulp 
 
The dental pulp is an innervated vascular connective tissue enclosed in dentine 
which is, in turn, covered by enamel and cementum. The hard layers provide 
the pulp with mechanical support and protection. There is also a close 
relationship between the pulp and dentine as they act as a unit and, hence, are 
commonly referred to as pulp-dentine complex (Pashley, 1996). The vitality of 
the pulp-dentine complex is important for several reasons. It acts as a sensory 
organ and is responsible for root development, tissue regeneration and repair 
(Manogue et al., 2005; Smith, 2002; Cooper et al., 2010). In addition, the ability 
of the complex to exhibit various defensive mechanisms, such as immune-
inflammatory responses and defensive dentine, is well recognised 
(Bergenholtz, 1990). 
 
1.2.2 Microbial role in pulpal disease 
 
Irritation of the pulp, leading to pulpal disease, may be caused by 
microorganisms, mechanical, thermal, electrical stimuli or radiation 
(Bergenholtz, 1990). However, the often cited work of Kakehashi et al in 1965 
indicated an aetiological role of microbes (Kakehashi et al., 1965). Using 15 
conventional and 21 germ-free rats, Kakehashi et al exposed dental pulps and 
observed that pulpal and apical disease only developed in the presence of 
microbes. In fact, exposed pulps in germ-free rats showed signs of repair. In 
agreement with this work, other studies were carried out on monkeys and 
reported similar observations (Moller et al., 1981; Moller et al., 2004). It is now 
widely accepted that although pulpal and apical disease may be initiated by 
non-infectious agents, the presence of microbes is essential for progression 
and perpetuation of the disease (Bergenholtz and Spangberg, 2004; 
Bergenholtz, 1990; Nair, 2004). 
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1.2.3 Microbial pathways to the pulp 
 
The most common route for microbial invasion is dental caries (Hargreaves et 
al., 2011) (Figure 1.1).  Microbes can also find other routes to pulpal space via 
non-carious tooth surface loss, traumatic or iatrogenic exposure of dentine. 
Periodontal disease, and/or treatment, may cause exposure of lateral or 
accessory canals. Idiopathic cervical resorption can provide a portal to the 
dentine tubules. There are cases where no apparent dentinal exposure is 
clinically evident. These can be attributed to enamel micro cracks, possibly 
resulting from trauma (Bergenholtz et al., 2007). Some also suggested that 
anachoresis, which is an infection of pulpal tissues caused by bacteria borne in 
the blood stream, is a possible avenue for microbial invasion (Fouad, 2009). 
In previously root filled teeth, however, the (re)infection occurs in a place where 
the bacteria are already, or have been, present. The most common cause is 
thought to be the persistence of microbes in the root canal after treatment or 
reinfection due to coronal leakage (Siqueira, 2001). 
 
 
Figure 1.1: Microbial pathways to dentine and pulp (Bergenholtz et al., 
2007). 
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1.2.4 The ecology of the infected pulp 
 
When the hard tissues are breached, commonly through caries, tooth wear, 
fractures or dental procedures, the dental pulp is exposed to noxious agents. 
The progress of the disease in the pulp is similar to other connective tissues 
and that includes inflammation (i.e. pulpitis) and later, if not treated, pulpal 
necrosis (Abbott and Yu, 2007). Within the necrotic pulp there are no defensive 
mechanisms and, thus, microbes colonise the pulpal space and multiply in 
large numbers (Bergenholtz and Spangberg, 2004). 
Factors that dictate the microbial ecology in a given niche include the local pH, 
abundance and partial pressure of oxygen, redox potential, availability of 
selective nutrients, and the state of local host defences (Marsh and Devine, 
2011). In canals with primary infection, there is a gradual shifting pattern in the 
root canal microbial composition (Sundqvist and Figdor, 2003). Pulpal exposure 
to the oral cavity and the availability of nutrition may favour aerobes and 
facultative anaerobes but at later stages the canal is dominated by obligate 
anaerobes. On the other hand, the harsh environment of secondary infections 
favours species with surviving abilities. There seems to be a high prevalence of 
facultative anaerobes such as enterococci and streptococci (Figdor and 
Sundqvist, 2007; Baumgartner, 2004). 
Planktonic microorganisms (free-floating) are a pre-requisite for biofilm 
formation (Svensäter and Bergenholtz, 2004). A biofilm is defined as a sessile 
multi-cellular microbial community characterized by cells that are firmly 
attached to a surface and enmeshed in a matrix of extracellular polymeric 
substances (EPS) (Siqueira et al., 2010). The first description of bacterial 
structure resembling biofilms in infected root canal was made by Nair (1987). 
Biofilms were also observed in secondary infections (Tronstad et al., 1990). 
 
1.2.5 The apical lesion 
 
Apical periodontitis develops following pulpal necrosis and the emergence of 
root canal infection. It represents a host defence response to prevent root canal 
infection from spreading into adjacent bone marrow spaces and other remote 
sites. Apical periodontitis may or may not present with clinical symptoms such 
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as pain, tenderness and swelling. Apical bone resorption, although 
representing tissue destruction, occurs as part of the defensive process. When 
root canal treatment is initiated and bacteria are effectively eliminated, the 
active inflammatory lesion gradually subsides and bone regeneration usually 
takes place (Bergenholtz et al., 2007). 
 
1.2.6 Root canal treatment 
 Aim and objectives of root canal treatment 
 
“Endodontology is concerned with the study of the form, function and health of, 
injuries to and diseases of the dental pulp and periradicular region, their 
prevention and treatment; the principle disease being apical periodontitis, 
caused by infection” (European Society of Endodontology, 2006). 
Non-surgical root canal treatment is usually indicated when the pulp is: 
 Possibly vital but (ir)reversibly inflamed, where the goal is to maintain 
existing periapical health and, thus, prevent apical periodontitis. 
 Necrotic or infected and associated with apical periodontitis and the goal 
is to restore apical health. 
Non-surgical root canal retreatment is indicated to treat secondary infections 
with failed previous root canal treatment and the goal is to restore the 
periradicular tissues back to health.  
The standard practice of nonsurgical root canal (re)treatment involves chemo-
mechanical preparation, with or without intracanal medication, root canal 
obturation and coronal restoration.  
 
1.2.7  Causes of root canal treatment failure 
 Intra-radicular infections 
 
The primary cause of root canal failure is the persistence, or reintroduction, of 
microbes in the root canal system (Siqueira, 2001). The risk of reintroduction of 
new microbes is dependent on asepsis, quality of obturation and coronal seal 
(Saunders and Saunders, 1994). Persistence of existing microbes is due to 
other causes; studies have demonstrated that, regardless of the technique, 
some parts of the root canal wall remain untouched by chemo-mechanical 
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preparation and therefore microbes may persist in these areas. Inadequate 
disinfection can also be caused by procedural errors such as instrument  
 
separation or ledges (Siqueira, 2001). Furthermore, microbes can escape 
disinfection steps by residing in unreachable areas such as accessory canals, 
isthmuses and dentinal tubules (Haapasalo et al., 2008). Failure may also be 
due to the presence of resistant microbes. Facultative species such as 
streptococci and Enterococcus faecalis have repeatedly been isolated and they 
possess the attributes to survive disinfection and harsh environmental 
conditions (Nair, 2006; Siqueira, 2001). 
Due to the above causes, and considering the known limitations of radiographs, 
one might understand why a seemingly well-treated tooth can fail (Kersten et 
al., 1987; Siqueira, 2001).  
 
 Extra radicular infections 
 
Apical periodontitis is perhaps a defence barrier to keep microbes within the 
confines of the root canal. However, bacteria may escape this barrier and 
reside on the root surface (Nair, 2006). Extra radicular infections may also be 
caused by extruded infected dentine chips or over instrumentation. The 
prevalence of extra radicular infection is low (about 6-10%) and only a few 
species can reside in the periradicular areas. The most isolated species are 
Actinomyces  and Propionibacterium spp. (Haapasalo et al., 2008). 
 
 Cysts 
 
Radicular cysts develop subsequent to apical periodontitis (Haapasalo et al., 
2008). Whether they heal after root canal treatment is a longstanding question. 
There are two types; pocket and true cysts. The former is expected to heal after 
conventional root canal treatment while the latter is self-sustaining and unlikely 
to heal (Nair, 2006). 
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 Foreign body reactions 
 
Foreign materials such as Gutta Percha (GP), sealer or paper points may 
become lodged in the periapical tissues and cause irritation and inflammation in 
the area (Haapasalo et al., 2008). 
 
 Scar tissue 
 
Apical lesions may heal by scar or fibrous tissue but this can be misdiagnosed 
radiographically as a sign of failure. Its prevalence is low (less than 7%) and it 
commonly occurs following surgical endodontics (Sathorn and Parashos, 
2008). 
 
 Microbiological Investigations of root canal microbiota 
1.3.1 Culture based studies 
 
The pioneer work of D.W Miller started an era in which culture based methods 
were the gold standard (Bergenholtz et al., 2007). Since then numerous 
culture-dependent studies have been conducted. Sundqvist et al. (1998) 
investigated 54 infected root filled teeth. In most cases each canal harboured 1-
2 bacterial species and only in one case there were four species in the canal. 
Sundqvist’s observations were in agreement with other studies (Molander et al., 
1998; Hancock et al., 2001; Pinheiro et al., 2003). More recently, Gomez et al 
(Gomes et al., 2004) investigated 41 necrotic pulps (primary infections) and 19 
failed root filled teeth (secondary infections). They observed that secondary 
infected canals contained 1-2 species while primary infections harboured up to 
ten species. In general, the majority of culture-based studies concluded that 
root canal infections consist of a few species (from 1-12 per canal) (Figdor and 
Sundqvist, 2007). 
Cultivation based methods have been invaluable for microbiology but they 
suffer from a number of inherent limitations. The major drawback is the inability 
to cultivate the vast majority of bacterial species (Siqueira Jr and Rôças, 2005). 
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1.3.2 Molecular based studies 
 
Deoxyribonucleic acid (DNA) was demonstrated as the genetic material by 
Oswald Theodore Avery in 1944. Its double helical strand structure composed 
of four bases was determined by James D. Watson and Francis Crick in 1953, 
leading to the central dogma of molecular biology (Fouad, 2009). The discovery 
of genetic material defines species and individuals, which makes the DNA 
sequence fundamental to the research on the structures and functions of cells 
and the decoding of life mysteries (Liu et al., 2012). 
The invention of the polymerase chain reaction (PCR) technique by Mullis was 
a revolution in microbiology which launched a new era of molecular 
identification (Mullis and Faloona, 1987). Since then an impressive array of 
PCR- based and other molecular techniques have been developed. There are  
several advantages of molecular based methods but perhaps the most 
important one is the ability to identify not only cultivable species, but also 
uncultivable taxa (Spratt, 2004). PCR is based on the in vitro replication of DNA 
through repetitive cycles of denaturing, primer annealing and extension steps. 
It was inevitable then that many investigators have used PCR and other 
molecular methods to study endodontic diseases. Sakamoto et al. (2008) 
investigated secondary infections using 16S ribosomal RNA gene clone 
libraries. They reported that most teeth harboured a mixed consortium with a 
mean number of ten taxa per case. Another study recruited 88 subjects with 
primary and secondary infections (Sedgley et al., 2006). They compared 
culture and real-time Quantitative PCR. The latter was able to detect bacteria in 
100% of the cases as opposed to 55% with culture methods. More recent 
techniques, such as checkerboard hybridization assays, have also been 
exploited when, for example, Rocas and Siqueira (2008) investigated chronic 
apical periodontitis in 43 patients. They found that the number of taxa per canal 
was directly related to the size of the apical lesion. Small lesions were 
associated with a mean of 11 taxa per canal, while canals in teeth with larger 
lesions harboured a mean of 20 taxa. Overall, molecular based studies 
demonstrated that infected root canals harbour between 10-30 species 
(Siqueira and Rocas, 2009a). 
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 Next generation sequencing technologies (NGS) 
1.4.1 Overview  
 
Next generation sequencing (NGS) technology, also known as high throughput 
or massively paralleling sequencing, is a blanket term that describes a number 
of modern technologies that are able to decipher the DNA, or RNA, with 
massive pace and depth (Margulies et al., 2005).  
The history of NGS started when Frederick Sanger developed a DNA 
sequencing technology based on a chain-termination method (Schuster, 2008). 
After years of development, Sanger sequencing, along with automated capillary 
electrophoresis, became the main tools for the completion of human genome 
project in 2001 (Collins and McKusick, 2001). 
The human genome project greatly stimulated the development of powerful 
novel sequencing instruments to increase speed and accelerated the 
development of NGS (Mardis, 2011).  
The NGS technologies are different from the Sanger method, which is now 
referred to as first generation technology, in three main aspects. First, instead 
of requiring bacterial cloning of DNA fragments they rely on the preparation of 
NGS libraries in a cell free system. Second, instead of hundreds, thousands-to-
many-millions of sequencing reactions are produced in parallel. Thirdly, the 
sequencing output is directly detected without the need for electrophoresis (Liu 
et al., 2012). 
Human microbiome analysis is the study of microbial communities found in and 
on the human body. The goal of human microbiome studies is to understand 
the role of microbes in health and disease (van Dijk et al., 2014). The advent of 
NGS started a revolution in metagenomic sequencing and analysis (the study 
of the collective genome of microorganisms from an environment). The 
increased throughput and decrease in costs of sequencing, coupled with 
additional technological advances have transformed the landscape of 
metagenomics (Scholz et al., 2012).  
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1.4.2 NGS instruments 
 
The first NGS instrument was Roche 454 by Life Sciences in 2005. Since then 
several instruments have been developed. Currently, as for 2013, there are 
four main technologies; 
 The Roche 454 (pyrosequencing) technique 
 The Illumina HiSeq 2000, HiSeq2500 and MiSeq platforms. 
 The SOLiD system 
 Ion Torrent semiconductor system. 
The various NGS technologies share the same principle of massive paralleling 
sequencing, but there are differences in their specifics such as sequencing 
chemistry, read length, running time, throughput per run and reads per run (Di 
Bella et al., 2013). The Illumina technology (Table 1.1) uses pair-ended 
overlapping reads which not only result in an increase of the total fragment 
length but also enhance the sequence quality (Kuczynski et al., 2012; 
Lazarevic et al., 2009). The Illumina MiSeq platform also have a very low error 
rate, compared with bench-top sequencers (Di Bella et al., 2013). 
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Table 1.1: The Illumina sequencing instruments. 
 MiSeq HiSeq2000 HiSeq2500 
Read length 50, 150, 250 or 
300 bp; single 
read or paired 
end 
50 or 100 bp, 
single read or 
paired end 
50, 100, or 150 
bp, single read or 
paired end 
Run time 6 hrs - 3 days 3-12 days 3-12 days in 
standard mode, 1-
5 days in rapid 
mode 
Data 
generated 
per lane 
1-25 million 
fragments 
sequenced in 
parallel; 0.5-15 
Gbases data 
output 
100-200 million 
fragments 
sequenced in 
parallel; 7.5-35 
Gbases data 
output 
100-150 million 
fragments 
sequenced in 
parallel; 7.5-35 
Gbases data 
output 
Uses prokaryotic ChIP-
seq, smallRNA-
seq, small 
genome 
resequencing and 
targeted capture 
RNA-Seq, large 
genome 
resequencing and 
targeted 
sequencing 
de novo genome 
sequencing, large 
genome 
resequencing and 
targeted 
sequencing; 
where quick data 
turnaround is vital 
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 Human microbiome investigation using NGS 
1.5.1 Oral microbiome 
 
Since NGS technologies have become available, a number of studies have 
been conducted to investigate and further exploit the microbiome of the oral 
environment. Keijser et al used 454 GS FLX pyrosequencing to investigate 71 
saliva and 98 supragingival samples (Keijser et al., 2008). They revealed a total 
of 28,978 unique variable (V6) tag sequences from 22 taxonomic phyla. 
However, the vast majority of these sequences (99.6%) belonged to one of the 
seven major phyla: Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria, 
Proteobacteria, Spirochetes, or candidate division TM7. The findings suggested 
more diversity in plaque bacteria than those in saliva, with 267 versus 185 
different genera, and 10,000 versus 5,600 OTUs at the 3% difference, 
respectively. Despite this, the bacterial richness estimated from rarefaction 
curves indicated that the richness is incomplete.  
Another study used Illumina Genome Analyzer system GAII to evaluate the 
depth of sequencing coverage (Lazarevic et al., 2009). The sequencing of 
saliva and oropharyngeal swabs from only three patients yielded a total of 
1,373,824 sequencing read of which 330,815 were unique taxa. The study 
claimed to achieve much greater depth of coverage than previous oral 
microbiota studies. Several other studies used NGS technologies to investigate 
the oral microbiome in  periodontal samples (Griffen et al., 2012), dental caries 
and periodontitis (Belda-Ferre et al., 2012), experimental gingivitis (Kistler et 
al., 2013) and healthy and failing implants (Kumar et al., 2012). Their findings 
gave new insights into the diversity of oral microbiota. 
 
1.5.2 Endodontic microbiome 
 
The first study to utilise NGS technologies for analysis of root canal infections 
was conducted by  Li et al (Li et al., 2010). Samples from seven teeth were 
collected with paper points and analysed using GS FLX pyrosequencing and 
Sanger sequencing. A total of 200,129 sequencing reads passed the quality 
assessment. The sequencing analysis at different taxonomic levels showed 
that Sanger sequencing and pyrosequencing yielded 8 vs. 13 phyla, 10 vs. 22 
classes, 11 vs. 43 orders, 20 vs. 97 families, and 25 vs. 179 genera, 
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respectively.  The most abundant phyla were Bacteroidetes (59.44%), 
Firmicutes (19.92%), Actinobacteria (4.79%), Fusobacteria (3.49%), 
Proteobacteria (3.18%), and Spirochetes (2.28%). The study detected six 
additional phyla that had not been previously reported in endodontic infections, 
namely: Tenericutes, Deinococcus-Thermus, Chloroflexi, Cyanobacteria, OD1 
and Acidobacteria. The majority of genera detected were present at relatively 
low abundance. The study not only revealed bacterial diversity in previously 
inaccessible endodontic microbiota but also allowed access to low-abundance 
bacteria. 
Siqueira et al. (2011) looked specifically at apical root canal microbiota using 
Multiplex tag encoded FLX titanium amplicon pyrosequencing. The sequencing 
of ten cryogenically ground apical root specimens yielded 84 genera belonging 
to ten phyla. The apical root region harboured a mean of 37 taxa, ranging from 
13-80, which was far greater than the previously reported mean of 3 species 
(range 2 -8) (Siqueira et al., 2007). A similar, more recent study also reported 
similar findings (Saber et al., 2012). Another group also compared chronic and 
acute root canal infections using pyrosequencing (Santos et al., 2011).Overall, 
13 phyla and 67 different genera were detected.  The results revealed that the 
bacterial diversity associated with acute infections is higher than chronic 
infections. The group also observed that there was a marked inter-individual 
variability in the composition of the bacterial communities. Each individual 
harboured a unique endodontic microbiota in terms of species richness and 
abundance. 
More recently, a study examined extracted teeth and compared coronal and 
apical microbiota (Ozok et al., 2012). They reported a far more complex apical 
diversity than previously highlighted.  Recently another five studies have been 
published looking at various aspects of root canal infections and they indicated 
that the diversity is far greater than previously anticipated (Lim et al., 2011; 
Hong et al., 2013; Anderson et al., 2013; Vengerfeldt et al., 2014; Tzanetakis et 
al., 2015). These are discussed in Chapter Five.   
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1.6 The study 
 
1.6.1 Aim 
To conduct a longitudinal study to investigate the microbiological diversity of 
root canal infections using high-throughput sequencing (HTS) on the Illumina 
MiSeq platform and culture methods. 
 
1.6.2 Objectives 
 
 To recruit (20) patients who are referred to Leeds Dental Institute with 
root canal infected teeth and require root canal treatment (pending 
fulfilment of inclusion criteria). 
 To provide subjects with standard root canal treatment or re-treatment. 
 To obtain valid pre and post-operative microbiological samples. 
 To analyse samples using culture and HTS methods. 
  
1.6.3 Primary question 
What is the microbial composition and load of infected root canals?  
 
1.6.4 Secondary questions  
1. Does the microbiological diversity differ between primary and secondary 
infections? 
2. Which species may persist after standard root canal treatment? 
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Chapter 2 Materials and Methods 
 Ethical approval 
Prior to the commencement of the study, ethical approvals (Appendices 1-3 for 
the research supporting documents) were sought and obtained from the 
following bodies: 
 National Research Ethics Service (NRES) Committee of Leeds East 
(REC reference number: 13/YH/0035, Appendix 4).  
 Leeds Research and Development Directorate (R&D) approval was 
obtained from Leeds Teaching Hospitals (LTHT R&D number DT 13/ 
10723, Appendix 5).  
 
 Clinical material 
2.2.1 Subjects 
 
The study population included subjects who had non-vital infected teeth with 
evidence of chronic apical pathology confirmed by: 
 Clinical signs and symptoms, such as tenderness to percussion, soft 
tissue palpation and/or presence of sinus tract. 
 Negative response to thermal and/or electrical pulp testing. 
 Apical radiographic changes that indicative of an apical pathology in line 
with clinical signs and symptoms. 
 
2.2.2 Inclusion criteria 
 
 Teeth with primary (previously untreated) or secondary (previously 
root filled) root canal infections. 
 Restorable teeth. 
 Stable periodontal condition and absence of periodontal pockets > 
4mm. 
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2.2.3 Exclusion criteria 
 
 Immune deficient patients such as HIV or leukaemia. 
 Pregnancy. 
 Under 18 years old. 
 Patients who had antibiotics in the last month. 
 Teeth with severe anomalies. 
 Cases where microbiological sampling may not be optimum or 
compromised by an ineffective coronal seal, for instance: 
1. Teeth with post(s). 
2. Teeth with root curvature of >15◦. 
3. Teeth which fail to show radiographic evidence of patent canals. 
 
 Sample size 
 
The sample size of this pilot study was determined following statistical advice 
by a qualified biostatistician at the Centre of Epidemiology and Biostatistics, 
University of Leeds. We proposed to aim for 20 subjects (or teeth) with an 
expected dropout rate of < 15%. This section is further discussed in Chapter 
Five. 
 Recruitment 
 
The study population was selected from patients who had been referred for root 
canal treatment to the new-patient Restorative Consultant Clinics, at the Leeds 
Dental Institute. The first contact and initial screening of potential participants 
were conducted by the duty restorative consultant as part of the consultation 
visit. Potential participants who appeared eligible for inclusion, and were 
interested in the study, were imminently met by the chief investigator for further 
screening and for provision of detailed information regarding the aims, duration, 
risks and benefits of the research as well as the procedures of the root canal 
treatment (or retreatment) and prognosis. They were then given participant 
information sheets and allowed a minimum of two days to freely consider taking 
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part in the study. Participants who agreed, were seen in the Leeds Dental 
Translational and Clinical Research Unit (DenTCRU) and asked to sign a 
consent form before re-confirming their eligibility and commencing the study.  A 
Case Report File (CRF) was allocated for each recruited participant with a 
unique number, to record relevant details, checklists and study data.  
 
 Withdrawal and exclusion 
Participants were completely free to withdraw from the study at any time 
without providing a reason. Participants could be excluded from the study for 
various reasons. Possible causes of exclusion included severe protocol 
deviation, eligibility violation, adverse events or changes to inclusion or 
exclusion criteria.  
 
 Clinical research team and settings 
The research was conducted in the Leeds Dental Translational and Clinical 
Research Unit (DenTCRU), the University of Leeds (Figure 2.1). The Unit is 
equipped with all materials and equipment required for the clinical research. 
The research team included two highly experienced dental nurses who were 
involved in designing research record documents, participants’ recruitment, 
record keeping, clinical treatment and patient management. 
 
 
Figure 2.1: DenTCRU unit at the Leeds Dental Institute. 
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 Endodontic treatment and clinical procedures 
The root canal (re) treatment, was delivered over three clinical visits in all cases 
according to the agreed protocol. The clinical treatment and materials used in 
the study were considered as standard with the exception of tooth surface 
decontamination and microbiological sample collection procedures (Figure 2.2). 
All the completed cases were relatively straightforward and, hence, the protocol 
was followed. The next section describes the clinical stages but first, and in 
order to avoid repetition, the following clinical steps are mentioned here 
because they were common in all visits.   
Each clinical session started with the following: 
1. Updating the medical history. 
2. Recording any changes or adverse events since the last visit. 
3. Re-confirming inclusion and exclusion criteria. 
After the administration of adequate local anaesthesia, the tooth was isolated 
with a sterile clamp (Claudius Ash, UK) and rubber dam (Coltene, Whaledent) 
and a caulking agent, Oraseal (Ultraden, Inc) to ensure a tight seal around the 
tooth.  
The tooth surface decontamination procedures were as follows: 
The tooth surface was polished with pumice and rinsed with sterile saline 
(Braun B, UK). Using a sterile cotton pellet, the tooth surface was then wiped 
with 3% (v/v) hydrogen peroxide (APC Pure, Manchester, UK) followed by 
2.5% (v/v) sodium hypochlorite (Henry Schien, UK) as described by Siqueira et 
al. (2004) and Sakamoto et al. (2008), which is a protocol modified from Ng et 
al. (2003). The tooth was washed with 3 ml of sterile saline, polished with 
pumice and washed again with 9 ml (3 full syringes) sterile saline to remove 
any remaining solution. Finally, the integrity of seal around the tooth was re-
checked and re-established when required.  
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Figure 2.2: Flowchart of the clinical procedures undertaken.  
Secondary infections Primary infections 
Tooth isolation. 
Field decontamination. 
Tooth access 
Coronal Flaring. 
S1 sample 
collection. 
Removal of old RF 
S1 sample 
collection. 
Commencement of RC preparation with 
hand instrumentation and 2.5% NaOCl. 
Ca(OH)2 dressing. Temporary restoration. 
Removal of Ca(OH)2 dressing. 
Completion of RC preparation. 
Ca(OH)2 dressing. 
Temporary restoration. 
 
Removal of Ca(OH)2. 
S2 sample collection. 
Obturation. 
Restoration. 
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2.7.1 1st Treatment visit 
 
The objectives of this visit were: 
 To gain tooth access. 
 To obtain a microbiological sample (sample S1) prior to chemo-
mechanical preparation. 
 To commence chemo-mechanical preparation 
 To adequately seal the tooth.  
Access through the tooth was gained with sterile high and slow hand pieces 
burs. Any caries present in the access cavity was removed and the previously 
described decontamination procedures were repeated. The next step varied 
depending on whether tooth had primary or secondary infection: 
 
 Primary infections 
 
After completing the removal of the pulp chamber roof, coronal flaring was 
performed with sterile SX ProTaper files (Dentsply Maillefer) and/or sterile 
Gate-Glidden burs (Dentsply). The canal’s width and length were explored with 
a K-file of at least size 20. Size 20 file should move relatively freely within the 
canal and be within 2mm of the apex. This was verified with an electronic apex 
locater (ZX, Morita, Tokyo, Japan) and/or periapical radiographs (PA).  If the 
canal was narrow or the file did not reach the working length, smaller files were 
used to enlarge the canal until it reached the required dimensions. To avoid 
disturbing the microbiota within the canal, only minimal irrigation with sterile 
saline was used at this stage. When the appropriate working length was 
accomplished, the S1 sample was collected as described in detail in Section 
2.8. After obtaining the S1 sample, initial root canal preparation was initiated. 
Hand instrumentation with ProTaper or K-flexofiles were utilised and 2.5% (v/v) 
sodium hypochlorite was used as an irrigant. The canal was then dried with 
sterile paper points (Plandent) and dressed with calcium hydroxide [Ca(OH)2] 
(Hypocal, Ellman). A sterile cotton pellet was placed before sealing with Glass 
Ionomer cement (Fuji JX, GC). 
  
 
22 
 
 
 Secondary infection 
 
Secondary infections are failed root-filled teeth. In the majority of the cases the 
old root filling was GP, except for two cases where the root filling materials 
were a silver point and a soft paste-like materials. 
The GP and paste-like material were removed as follows; after gaining straight 
access to the root filling, every effort was made to remove the root filling 
mechanically using a combination of Gates- Glidden, ProTaper retreatment 
files, Hedstrom files (QED) and/or K-files (QED). This proved sufficient in the 
majority of cases. However, in two cases a solvent (EndoSolv) was required to 
soften the gutta-percha and complete the removal of the root filling. This was 
vital to avoid jeopardizing the treatment outcome. To minimise any possible 
further damage to the microbiota of the canal, the only irrigant used at this 
stage was sterile saline. The complete removal of the root filling was confirmed 
with a periapical radiograph. Following this, the S1 sample was obtained as 
described in Section 2.8. After obtaining the S1 sample, initial canal disinfection 
and preparation was initiated. Hand instrumentation with ProTaper or K-files 
were utilised and 2.5% (v/v) sodium hypochlorite was used as an irrigant. The 
canal was then dried with sterile paper points and dressed with Ca(OH)2. A 
sterile cotton pellet was placed and the tooth was sealed with Glass Ionomer 
cement. The silver points and separated instrument case were a 
straightforward case. The silver point was relatively loose and was grasped and 
removed with Removal forceps. Following this, the S1 sample was obtained 
and stored for further processing. 
 
2.7.2 2nd Treatment visit 
 
The objectives were: 
 To re-access the tooth. 
 To complete canal preparation and disinfection procedures. 
 To reseal the tooth. 
After the administration of the local anaesthesia and tooth isolation as 
described in the first treatment visit, the canal was re-accessed with sterile burs 
as described previously. Using hand files and irrigation, the Ca(OH)2 dressing 
23 
 
was removed from the canal. Mechanical preparation of the canal was 
completed with hand instrumentation using ProTaper files and/or K-files. The 
researcher was free to choose either file type and the preparation technique as 
judged appropriate for a particular case. Copious amount of 2.5% (v/v) sodium 
hypochlorite was used throughout the preparation. The exact amount of the 
irrigant solution varied according to the case, which depended mainly on the 
size of the canal and the amount of preparation needed. As a general rule, the 
researcher used at least a full 3 ml syringe every other file use. The final 
irrigant was sterile saline solution. The canal was then dried with sterile paper 
points. Non-setting Ca(OH)2 was then placed in the canal with a long intracanal 
syringe to the full working length. A sterile cotton pellet was then placed and 
the tooth was sealed with glass ionomer cement.  
 
2.7.3 3rd Treatment visit  
 
The objectives were: 
 To re-access the tooth. 
 To remove the dressing. 
 To obtain the S2 sample immediately prior to obturation. 
 To obturate the canal. 
 To restore the tooth. 
After the usual checks, the canal was re-accessed with burs as described in the 
first visit. Using hand files and irrigation, the Ca(OH)2 dressing medication was 
removed from the canal. The canal was then copiously irrigated with sterile 
saline to remove any remnant of Ca(OH)2 and then dried with sterile paper 
points. Master cone periapical radiographs were obtained to confirm the length. 
Just prior to obturation, the S2 sample was obtained as described in Section 
2.8. To complete the obturation of the tooth, the master cone was coated with 
Zinc Oxide based sealer (Tubliseal, Kerr) and the obturation was completed 
with GP (Dentsply). The cold lateral compaction technique was utilised in all 
cases. The GP was then cut at the cemento-enamel junction, sealed with 
VitroBond (3M, ESPE) and the tooth was restored with glass ionomer cement. 
A post-operative radiograph was obtained. The patient was then fully informed 
about possible treatment outcome and future reviews. At this point their 
participation in the clinical treatment was completed. In most cases patients 
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were referred back to their referring clinician for permanent restoration and 
future reviews. 
 
 Microbiological sample collection 
 
Root canal biofilm samples were collected following the protocol described by 
Moller (Moller, 1966). In total, two samples were collected from each subject: 
 (S1) was collected prior to chemo-mechanical preparation.  
 (S2) was collected immediately prior to obturation. 
 
The sample collection procedures were as follows: 
The canal was filled with about 0.5-2 ml of sterile saline. A new sterile surgical 
glove was worn before sampling and a sterile file (Dentsply, UK) of at least size 
20 was introduced into the canal and moved with gentle filing motion to disrupt 
the biofilm. The file was then placed in the sample collection tube (Bijou) which 
contained 1.5 ml of reduced transfer fluid (RTF, containing; 0.45 g of K2HPO4, 
0.45g of KH2PO4, 0.90 of NaCl, 0.1875 g of (NH4)2SO4, 0.40 g of Na2CO3, 0.20 
g  of Dithiothreitol, 10 ml of 0.1 M EDTA and 1000 ml of distilled water). A 
sterile paper point was then inserted in the canal to the full working length to 
absorb the canal contents and then transferred to the collection tube. This was 
repeated until all fluid and biofilm were absorbed. In multi rooted teeth, the 
sample was collected from the canal with the apical pathology.  
Upon collection, the sample was immediately placed in a jar with an anaerobic 
gas generating sachet and immediately transferred to the oral microbiology 
laboratory. Upon arrival, the collection tube was vortexed for 30 seconds and 
then placed in the anaerobic workstation for further laboratory analyses. 
  
25 
 
 
 Laboratory procedures and experiments 
Laboratory procedures flowchart (Figure 2.4). 
 
2.9.1 Optimisation experiment 1 
 Sampling technique and number of paper points 
 
Optimisation of the sampling technique was performed, by estimating the 
number of paper points required for sample collection to obtain the maximum 
amount of microbial material. 
Two extracted single rooted lower right canines were accessed by sterile burs 
and placed in two sterile bijou containers. The canal in each tooth was 
inoculated with 2 ml of freshly obtained saliva from the researcher and Brain 
Heart Infusion (BHI) was used as growth medium. This was incubated in a 
walk-in incubator at 37oC for 5 days. After the incubation period, two different 
sample collection methods were performed. The first sampling method was as 
described in Section 2.8 , while in the second method only 3 paper points were 
used.  The DNA was extracted using the QIAGEN DNA mini kit as described in 
Section 2.9.6. The main conclusion from this experiment was that the first 
sampling method yielded significantly more DNA than the second and, hence, it 
was used in this study. 
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2.9.2 Initial microbiological sample preparation 
 
Microbiological sample preparation steps were completed in the anaerobic 
work station (Concept 1000 INVIVO2, RUSKINN) under strict aseptic 
conditions using sterile instruments (Figure 2.3). As mentioned above, each 
sample was placed in 1.5 ml of RTF in a Bijou container. The sample was then 
divided into two aliquots; the first aliquot comprised 1.2 ml of the sample 
pipetted into a 1.5 ml microcentrifuge tube and this was designated for DNA 
processing while the remaining 300 μl was utilised for culturing. 
 
 
 
Figure 2.3: Anaerobic work station (Concept 1000 INVIVO2, RUSKINN). 
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Figure 2.4: Flowchart of the laboratory procedures 
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2.9.3 Microbiological culture experiments 
 
Due to the low volume of samples aliquoted for carrying out the culturing 
(300µl), it was decided to utilise the whole volume for serial dilution and not to 
include a neat sample in the analyses. Initially, for the first few microbiological 
samples, a 10-fold serial stepwise dilution was performed to dilute each sample 
from 10-1 to 10-5. However, after observing that there was too little or no 
microbial growth on all plates with higher dilutions, it was decided to use 10-3 as 
the highest dilution. The procedures were as follows. Three clean 7 ml 
polystyrene bijou containers were used and labelled as 10-1, 10-2 and10-3 . 2700 
µl sterile RTF was added to each container. The 300 µl sample was transferred 
to the 10-1 dilution and then thoroughly mixed by shaking and pipetting. This 
was repeated for the other two dilutions. 
After completing the serial dilutions, 100 µl was plated, and spread using 
disposable spreaders, on various selective and nonselective media, in triplicate 
and the incubated as described in Table 2.1. 
 
Table 2.1: The media selected for the study and the incubation conditions. 
Total count or 
group 
Medium Incubation 
Anaerobic/Aerobic 
Temp. Incubation 
time 
Total anaerobic CBAa 
anaerobic 
Anaerobic 37 ºC 7 days 
Total aerobic CBA 
aerobic 
Aerobic 37 ºC 7 days 
Actinomyes 
spp. 
CFATb Anaerobic 37 ºC 7 days 
Bifidobacterium 
spp. 
Mupirocin-
based 
selective 
agar 
Anaerobic 37 ºC 7 days 
Lactobacillus 
spp. 
Rogosa 
agar 
Aerobic 37 ºC 7 days 
Yeast Sabouraud 
agar 
Aerobic 37 ºC 7 days 
Mutans 
streptococci 
TYCSB 
agarc 
Anaerobic 37 ºC 7 days 
  
                                            
a CBA- Colombia Blood Agar.  
b CFAT- Cadmium Sulfate Fluoride Acridine Trypticase Agar. 
c -TYCSB- Tryptone Yeast Extract Cystine with Sucrose and Bacitracin Agar. 
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2.9.4 Culture data analyses 
 Variables collected 
 
Microbial counts for pre- and post-operative samples were expressed as the 
number of colony forming units (cfu)/ml. Descriptive statistics such as mean 
and standard deviation were used to summarise the data. 
 
 Statistical analyses 
 
The data collected from each case were entered into Microsoft Office Excel 
2010 spreadsheets. Differences between primary and secondary samples and 
between S1 and S2 samples were statistically tested. Logarithmic 
transformation was applied to the original observations (cfu/ml) to make the 
distribution more symmetric.  A paired t-test was used to evaluate the 
difference between S1 and S2 samples collected from the same individual. An 
independent two sample t-test was used to test the difference between primary 
and secondary infection samples. Unequal variance between two samples was 
assumed.  All tests were performed using IBM SPSS Statistics Version 21.  
 
 
2.9.5 Sample DNA preparation for NGS 
 
 Optimisation experiment 2 
2.9.5.1.1 Comparisons of DNA extraction kits: 
Freshly collected saliva samples were tested using two different DNA extraction 
kits; QIAamp DNA mini kit (Qiagen) and UltaClean Microbial DNA isolation kit 
(MOBIO Laboratories). The kits were used according to the manufacturer’s 
protocols. The main result indicated a higher DNA yield was obtained from the 
saliva samples using the QIAamp, DNA mini kit (Qiagen) and hence it was 
used for study. 
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2.9.6 DNA extraction procedures 
 
The second aliquot contained 1.2 ml of the microbiological sample and this was 
designated for DNA extraction. DNA was extracted using the QIAamp DNA 
Mini Kit (Qiagen), and following the manufacturer’s protocol. The extraction 
procedures were as follows; the sample was centrifuged for 10 minutes at 7500 
rpm to isolate the bacterial pellet and this was re-suspended in 180 µl Buffer 
ATL. To lyse the bacterial cells in the sample, 20 µl proteinase K was added, 
mixed by vortexing for 30 seconds and incubated for 3 hours at 56oC. Vortexing 
was repeated for 30 seconds every hour as recommended by the 
manufacturer. At the end of the incubation, a brief centrifugation was performed 
to remove the drops from the lid. 200 µl Buffer AL was then added to the 
sample, mixed by vortexing and incubated for 10 minutes at 70°C to produce a 
homogeneous solution. Next, 200 µl absolute ethanol was added and, after 
vortexing the sample for 15 seconds, the whole mixture was transferred to the 
QIAamp Mini spin column (in 2 ml collection tube). This was then centrifuged 
for 1 minute at 8000 rpm. The collection tube containing the infiltrate was then 
discarded and replaced with a new 2 ml collection tube. Following this, 500 µl 
Buffer AW1 was added and the sample centrifuged at 8000 rpm for 1 minute. 
After discarding the collection tube containing the infiltrate and replacing it with 
a new 2 ml collection tube, 500 µl Buffer AW2 was added and the sample 
centrifuged at full speed (14000 rpm) for 3 minutes. Next, the collection tube 
was discarded but this time replaced with a 1.5 ml microcentrifuge tube. Finally, 
200 µl Buffer AE was added to the sample, incubated at room temperature for 
1 minute and then centrifuged for 1 minute at 8000 rpm. The spin column was 
discarded and the 1.5 ml microcentrifuge tube containing the sample DNA in a 
200 µl volume was stored at – 20°C.  
 
2.9.7 Measurement of extracted DNA concentration in the samples 
 
Measurement of the DNA concentration in each sample was conducted using 
the Quant-iT PicoGreen Kit (Invitrogen, Paisley, UK). The protocol described 
below was sufficient for five samples and the standard DNA, in duplicate. 
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 Preparation of the assay buffer 
 
6000 µl 1X TE buffer was prepared from 20X TE buffer by adding 300 µl of 20X 
TE to 5700 µl of DNase free water. This working solution was intended for the 
reagent, standard DNA and the micro-well plate preparation. 
 
 Preparation of reagent 
 
A 200 fold dilution of the PicoGreen reagent was prepared in a Bijou container 
by adding 10 µl of reagent to 1990 µl of TE buffer from Section 2.9.7.1. The 
prepared reagent was maintained away from direct light. 
 
 Preparation of the standard DNA 
 
The DNA concentration was expected to be low and, hence, the low-range 
standard curve was selected. The low range protocol included two steps; 
2.9.7.3.1 Step 1; a 50X fold dilution of the 2 µg/ml of stock DNA was prepared 
by adding 1 µl of the stock DNA to 49µl TE buffer.  
2.9.7.3.2 Step 2; from this, 10 µl was pipetted and added to 390 µl of TE buffer, 
in a 1.5 microcentrifuge, to prepare 40X fold dilution to yield 50 ng/ml 
of stock DNA. 
The standard DNA was then added to a microwell plate according to Table 2.2, 
below. 
Table 2.2: Low range standard DNA distribution. 
Vol of TE 
(µl) 
Vol of 50 ng/ml stock 
DNA (µl) 
Final DNA conc. in PicoGreen 
assay 
0 100 25 ng/ml 
50 50 12.5 ng/ml 
90 10 2.5 ng/ml 
99 1 250 pg/ml (0.25 ng/ml) 
100 0 0 
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 Preparation of micro-well 
 
The micro well plate was labelled in duplicate to receive the samples containing 
the extracted DNA (Figure 2.5, A). The well was prepared by first pipetting 99 
µl of TE into each well and then adding 1 µl of each sample in the 
corresponding well. Finally, 100 µl of the reagent prepared from Section 
2.9.7.2, was added to each well. The micro-plate was then ready for analysis 
using the spectrofluorometer (Figure 2.5, B). 
 
 
Figure 2.5: A: Well plate example. The first 2 lanes occupied with the 
standard DNA. The sample DNA is placed in duplicate. B: The 
spectrofluorometer (Varioscan flash, Thermo). 
  
A 
B 
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2.9.8 NGS library generation 
 
The following protocol describes the steps carried out to amplify the targeted 
16SrRNA gene V3-V4 regions of the bacteria present in each of the collected 
samples, and processes required to prepare the purified DNA fragments for 
next generation sequencing. 
 
 Optimisation experiment 3 
2.9.8.1.1 Evaluation of various primer combinations 
 
The aim was to compare 347F/ 803R primers to the V4F/V4R primer 
combination using the Master Green TAq kit. Extracted DNA samples from 
saliva were amplified using the Master Green TAq Kit and the two primer 
combinations. The PCR products were checked using agarose gel 
electrophoresis which showed that more PCR products were obtained using 
347F/803R primers and, hence, these were used in the study. 
 
 Optimisation experiment 4 
2.9.8.2.1 Optimisation of PCR conditions 
 
The aim was to compare two different melting temperatures (Tms) for the 347F/ 
803R primers using the Q5 High Fidelity DNA polymerase kit. Extracted DNA 
samples from saliva were amplified under two different Tms (60 and 63oC). The 
PCR products were checked using agarose gel electrophoresis. No significant 
difference was observed between the two primer Tms. 
 
2.9.9 Polymerase Chain reaction (PCR) 
 Amplification of the extracted DNA 
 
The 16S rRNA gene is about 1542 basepairs (bp) long and contains nine 
hypervariable (V) regions interspersed within conserved regions. For the 
present study, the third (V3) and fourth (V4) hypervariable regions were 
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targeted for amplification using the Q5 High Fidelity DNA polymerase kit (New 
England BioLabs Inc., Life Technologies Inc. US) according to the 
manufacturer’s protocol. The forward 347F and reverse 803R (Eurogentec, 
Belgium) universal bacterial primers were used for the process (Table 2.3). 
 
Table 2.3: The forward and reverse primer sequences used for PCR. 
Primer Sequence  Bases 
347F 5’-GGA-GGC-AGC-AGT-RRG-GAA-T-3’ 19 
803R 5’-CTA-CCR-GGG-TAT-CTA-ATC-C-3’ 19 
 
After thawing all the reagents on ice, they were gently vortexed and briefly 
centrifuged. The components of the reaction master mixture were first 
prepared, without the template DNA, in a 2 ml collection tube (Table 2.4). The 
master mixture was then distributed as aliquots of 23 µl in individual 0.5 ml 
PCR tubes. 2 µl of the templates DNAs were added to the individual PCR tubes 
to complete a total volume of 25 µl of PCR reaction mixture as recommended 
by the manufacturer. 
 
Table 2.4: Master mix agents and their volumes for each PCR tube. 
Component Volume (µl) 
5X Q5 reaction buffer 5 
10 mM dNTPs 0.5 
10 mM 347F primer 1.25 
10 mM 803R primer 1.25 
template DNA 2 
High fidelity DNA polymerase  0.25 
5X Q5 enhancer 5 
Nuclease free water 9.75 
Total 25 
 
 
The individual PCR tubes were gently centrifuged to collect all components in 
the bottom of the tube and were then loaded onto the Prime thermal cycler 
(Techne, Bibby Scientific, UK) using the PCR conditions described in Table 2.5, 
below.  
 
 
35 
 
Table 2.5: The thermocycling conditions for the PCR. 
Step Temperature Time 
Initial Denaturation 98 oC 30 seconds 
35 
cycles: 
Denaturation 
Annealing 
Extension 
98 oC 
60 oC 
72 oC 
10 seconds 
30 seconds 
30 seconds 
Final extension: 72 oC 2 minutes 
Hold: 10 oC  
 
2.9.10 DNA Gel electrophoresis 
 
The presence of PCR products was checked using agarose gel 
electrophoresis. The agarose gel was prepared by adding 0.42 g of agarose 
(Severn Biotech limited, Worcester, UK) to 60 ml of 1X TAE Buffer (Tris-
acetate-EDTA) (Sigma, Gillingham, UK) and then heating the solution in a 
microwave in several short intervals until the agarose was completely 
dissolved. 1 µl of GelRed DNA stain (Biotium, UK) was then added to the 
solution which, after a thorough mixing, was poured into a gel casting tray. One 
or two, gel comb(s) was placed in the tray to generate the wells and the 
solution was allowed to set at room temperature for at least one hour. 
After the gel was set, sufficient TAE buffer was added to cover the tray and the 
wells. The samples were then prepared by thoroughly mixing 2.5 µl of the PCR 
product with 1 µl of Bromophenol Blue dye using a pipetter on a sterile paraffin 
film sheet. After mixing and loading the samples onto the gel, it was run using 
the Power Pac 300 (RioRad, USA) at 100 V, 400 mA for about 20 minutes. The 
gel was visualised using the Bio-Rad (ChemiDoc MP) Ultraviolet image system.     
 
2.9.11 PCR product sample Clean up 
 
MicroCLEAN (Microzone Ltd, UK) was used to purify the PCR product 
samples. 23 μl of the microCLEAN solution was added to the PCR product and 
thoroughly mixed by pipetting. The solution was centrifuged at 13000 rpm for 5 
minutes and then the supernatant was carefully removed. The solution was 
centrifuged again for 2 minutes and the supernatant was removed. The DNA 
pellet was resuspended in 55.5 µl of nuclease-free water (Ambiol).  
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2.9.12 Addition of adaptors and indexes 
 
 NEBNext End preparation 
 
After thawing all reagents on ice, 55.5 µl of the DNA sample produced from 
Section 2.9.11, was mixed with 3.0 µl End Prep Enzyme mix and 6.5 µl of End 
Repair Reaction Buffer (10X) to yield a total volume of 65 µl. After mixing by 
pipetting and a quick spin to collect the liquid from the side of the tube, the 
mixture tube was placed in the Prime thermal cycler (Techne, Bibby Scientific, 
UK) using the program Table 2.6, below. 
 
Table 2.6: Thermal cycle settings for the End preparation. 
Time Temperature oC 
30 minutes 20 
30 minutes 65 
Hold 4 
 
 Adaptor ligation 
 
Next, 15 µl Blunt/TA ligase master mix, 2.5 µl NEBNext Adaptor for Illumina 
and 1 µl ligation enhancer were directly added to the end Prep reaction 
mixture. After thorough mixing by pipetting and a brief centrifugation, the 
mixture was incubated at 20 oC for 15 minutes in the Prime thermal cycler 
(Techne, Bibby Scientific, UK). 3 µl of USER Enzyme was added to the ligation 
mixture and mixed before another 15 minutes incubation at 37 oC in the Prime 
thermal cycler. 
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 Clean up of adaptor ligated DNA (without size selection) 
 
AMPure XP beads (Beckerman Coulter, Inc) were first placed at room 
temperature and resuspended by vortexing. 86.5 µl of the beads were added to 
the ligation mixture, mixed by pipetting and vortexing before incubation for 5 
minutes at room temperature. Following a quick centrifugation, the tube was 
placed on a magnetic stand to separate the beads from the supernatant and 
left for about 5 minutes until the solution was clear. The supernatant was then 
carefully discarded without disturbing the beads that contained the DNA 
targets. The beads were washed, while on the magnetic stand, by adding 200 
µl of 80% (v/v) freshly prepared ethanol (Sigma, UK) and then incubated for 30 
seconds before carefully removing the supernatant. After repeating this for a 
total of three times, the beads were further air dried for 10 minutes. To elute the 
DNA target from the beads, 28 µl of 0.1X TE was added, mixed by pipetting, 
quickly centrifuged and then placed on the magnetic stand until the solution 
was clear. Finally, 23 µl of the solution is transferred to a new PCR tube for 
amplification.       
 
 PCR amplification 
 
The 23 µl of the adaptor ligated DNA mixture produced in the last clean up step 
was mixed with: 
 25 µl of NEBNext High Fidelity 2XPCR master mix. 
 1 µl of universal PCR primer, and 
 1 µl of Primer Index 1-38 (one index for each sample). ( Table 2.7 for 
adaptor and universal primer sequence) (Appendix 6 for a list of all 38 
primer indexes). 
Table 2.7: NEBNext adaptor and universal primer sequences. 
Component Sequence 
NEBNext 
adaptor 
5’ -/5Phos/GAT-CGG-AAG-AGC-ACA-CGT-CTG-AAC-
TCC-AGT-C/ideoxyU/A-CAC-CAC-TCT-TTC-CCT-ACA-
CGA-CGC-TCT-TCC-GAT-C*T-3’ 
NEBNext 
Universal primer 
5’-AAT-GAT-ACG-GCG-ACC-GAG-ATC-TAC-ACT-CTT-
TCC-CTA-CAC-GAC-GCT-CTT-CCG-CTT-CCG-ATC*-T-
3’ 
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After mixing by pipetting and a brief centrifuge, the mixture tubes were then 
placed in the Prime thermal cycler for PCR amplification using the following the 
conditions presented in Table 2.8, below. 
 
Table 2.8: PCR conditions. 
Step Temperature 
oC 
Time Cycles 
Initial 
denaturation 
98 30 seconds 1 
Denaturation 
Annealing 
Extension 
98 
65 
72 
10 seconds 
30 seconds 
30 seconds 
 
15  
 
Final extension 72 5 minutes 1 
Hold 4   
 
 Clean up of PCR amplification 
 
AMPure XP beads (Beckerman Coulter, Inc) were first placed at room 
temperature and resuspended by vortexing. 50 µl of the beads were added to 
the PCR reaction mixture, mixed by pipetting and vortexing before incubation 
for 5 minutes at room temperature. Following a quick centrifugation, the tube 
was placed on a magnetic stand to separate the beads from the supernatant 
and left for about 5 minutes until the solution was clear. The supernatant was 
then carefully discarded without disturbing the beads that contain the DNA 
targets. The beads were washed, while on the magnetic stand, by adding 200 
µl of 80% (v/v) freshly prepared ethanol (Sigma Aldrich, UK) and then 
incubated for 30 seconds before carefully removing the supernatant. The beads 
were further air dried for 10 minutes while the PCR plate was on the magnetic 
stand and lid open. To elute the DNA target from the beads, 33 µl of 0.1X TE 
(Life technologies, UK) was added, mixed by pipetting, quickly centrifuged and 
then placed on the magnetic stand until the solution was clear. Finally, 28 µl of 
the supernatant was transferred to a new PCR tube and stored at -20 oC  for 
next stage. 
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2.9.13 Assessment of amplicon sizes 
 
The Agilent D1000 ScreenTape system (Agilent technologies Inc., Germany) is 
a tape-based platform for a simple, fast and reliable electrophoresis to verify 
the amplicon sizes of each sample from the final library preparation (Figure 2.6)  
The system consists of three elements;  
 2200 TapeStation system. 
 D100 ScreenTape with D1000 Reagents (D1000 ladder, D1000 Sample 
buffer), and 
 Agilent 2200 TapeStation software. 
This laboratory procedure was entirely performed by the NGS facility at the 
University of Leeds, St James Hospital. 1 µl from each DNA sample was 
utilised, without dilution, to prepare for this analysis. Upon completion of the 
procedure, the results of the analyses were collected and stored on a USB 
drive. 
Using the 347F/803R primers, and after the addition of primers and adapters, 
the expected library DNA amplicon size should exceed 490bp which is 
recommended by Illumina in order to achieve an overlap of approximately 
50bp.  
 
Figure 2.6: TapeStation instrument (Agilent technologies Inc.) 
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2.9.14 Libraries quantification and normalization 
 
The Qubit Kit Assays (Invitrogen, Life Technologies), a fluorometric-based 
quantification method that uses DNA (RNA or protein) binding dyes, was 
utilised to quantify the libraries. Before the start of the process, the DNA 
samples and standards were thawed on ice (at about 4 oC) whereas the Qubit 
buffer and reagent were stored at room temperature. The working solution was 
prepared by diluting the Qubit reagent 1:200 in Qubit buffer. This was first 
prepared as a master mix sufficient for a total of 76 samples (38 samples in 
duplicate) as well as for two standard tubes. The individual assay tubes were 
prepared in a clear 0.5 PCR tubes according to Table 2.9, below. 
 
 
Table 2.9: Volumes for preparing individual assays for Qubit. 
Volume Standard 
assay tubes 
Sample 
assay tubes 
Vol of working solution to add 190 µl 199 µl 
Vol of standard to add 10 µl 0 
Vol of DNA sample to add 0 1 µl 
Total vol in each assay tube 200 µl 200 µl 
   
 
 
 
After this, the tubes were briefly vortexed and then incubated for 2 minutes at 
room temperature. Finally the tubes were inserted in the Qubit 2.0 Fluorometer 
to obtain the concentration readings in mg/ml.  
 
 
 
 
41 
 
 
The Qubit readings were utilised for library normalisation. Using the average of 
the two readings, the volume required to obtain 100 ng was calculated 
according to the following equation and example presented in Table 2.10, 
below. 
 
Average of conc.  (n) ng/µl        =    100 ng/ volume (X) µl 
 
Table 2.10: An example for calculating the final volume from each sample. 
Sample 1st  reading 2nd reading Average 
001S1 47.2 ng/µl 31.2 ng/µl 39.2 ng/µl 
(X) µl = 100 / 39.2 = 2.6 µl    
 
The final multiplexed indexed library was pooled by added the calculated 
volumes from each sample into a single 2.0 ml collection tube. This was 
transferred to the NGS facility (Clinical Science Building, St James’ hospital 
campus, University of Leeds). 
 
  MiSeq final sample preparation, loading and running 
 
This part was conducted by the NGS facility’s staff. The collection tube 
containing the multiplexed pooled library was transferred to the NGS facility to 
be run with 2x 300 bp pairs. A sample sheet containing sample codes, 
universal primers, adaptors and unique indexes sequences had been 
completed in an excel sheet and transferred to the NGS facility as requested.  
After the MiSeq running (Figure 2.7), the raw data files, generated as Fast files 
were electronically dispatched to the chief investigator for further analyses.   
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Figure 2.7: MiSeq benchtop platform. 
 
  Sequencing analyses and data processing 
 
Data handling was carried out using the Advanced Research Computing (ARC) 
available at the University of Leeds, which basically consists of  a constellation 
of High Performance based servers and storage. Access to and files transfer to 
ARC was facilitated using MobaXTerm v7.6 (Figure 2.8) and FileZilla v3.10.3 X 
server software (Figure 2.9
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Figure 2.8: Screenshot of the MobaXTerm application. 
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Figure 2.9: Screenshot of the FileZilla application. 
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The raw sequencing data generated by the MiSeq instrument were stored as 
Fastq files (with quality score encoded with a single ASCII). Final data 
processing and analyses were carried out using Quantitative Insights Into 
Microbial Ecology (QIIME), which is an open-source bioinformatics pipeline for 
performing microbiome analysis from raw DNA sequencing data. Prior to using 
QIIME, the fastq files were pre-processed as follows; the linker primer 
sequences were removed from the reads and then the reads were re-joined 
again.  These steps were carried out using cutadapt v1.8 and fastq-join 
computer programs. The fastq files were then converted to fasta files using a 
script (computer commands) constructed using Python v2.7.10 (Figure 2.10).  
QIIME was then used to process the sequences into OTUs. This was done in 
several steps according to Table 2.11, below. 
Table 2.11: Steps for data processing using QIIME. 
1. Pick OTUs The sequences clustered into (OTUs) Using the 
default uclust matching, (0.97 sequence similarity).  
2. Pick representative To be used for taxonomic identification of the OTU 
and phylogenetic alignment 
3.Assign taxonomy To compare OTUs against a Greengenes (GG) 
database 
4. Make OTU table  
5. Align sequences De novo and assignment using PyNAST 
6. Filter alignment 
command 
 
7. Build phylogenetic 
tree command 
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Figure 2.10: An example of data analysis script generated using Python. 
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The data produced were then used to obtain the following analyses:  
 Heat map was generated using OUT table. 
 Assessment of community diversity within a sample (alpha diversity) or 
between a collection of samples (beta diversity). 
 Jackknifing analysis to measure robustness of the sequencing effort. 
This was produced as jackknifed weighted 3d PCoA plots and jackknifed 
trees.  
 Shared OTUs to assess similarities between primary and secondary 
samples. 
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Chapter 3 Results 
 Demographic data 
 
Details of demographic and clinical data are shown in Table 3.1.Twenty two 
teeth, from 19 participants, were recruited for the study. Three teeth from three 
participants were excluded from the study, two of which were due to 
subsequent violation of exclusion criteria and the third was due to failed 
screening. 
Sixteen participants (19 teeth) completed the study. The participants were 12 
females and four males with a mean age of 43 years (range 20-67 y, SD= 
12.71).  Ten of the 19 teeth were diagnosed with primary infection as opposed 
to nine teeth with secondary infection. The 19 teeth included 12 incisors, three 
premolars and four molars. The maxilla was represented by 14 teeth while five 
teeth were present in the mandible.  
Regarding clinical symptoms at baseline, 11 teeth had initially presented with 
mild pain or discomfort while the rest were pain free. Reduction of pain was 
reported by patients during visits in most cases and at the final visit, all showed 
very mild or no symptoms. Soft tissue changes were observed in eight cases, 
five of which were swellings and the rest were sinus tracks.  
With regards to the radiographic radiolucency of the recruited teeth, all teeth 
included in the study showed radiographic changes at the start of the 
treatment. This was recorded into three categories as;  
 Only widening of periodontal ligament (and/ or loss of lamina dura);  
 Less than 10 mm in diameter of apical radiolucency ; or 
 More than 10 mm diameter of apical radiolucency.  
Of those recruited, 14 patients presented a radiolucent lesion of < 10 mm in 
diameter of apical radiolucency, three cases presented with cyst-like lesions of 
>10 mm in diameter and two presented with only widening of periodontal 
ligament.
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Table 3.1: Demographic and clinical data of teeth included in the study. 
      Soft tissue Radiolucency 
Participants Age (years) Gendera Toothb/Canalc Infection Discomfort/Pain Sinus swelling Only Widening of PLd <10mm >10mm 
SUB-001 25 F LR6/D Primary Yes No Yes No Yes No 
SUB-002 67 F UR4/P Secondary No No No No Yes No 
SUB-003 34 F LR7/D Primary Yes No Yes No Yes No 
SUB-006 28 F UR1 Primary No No No No Yes No 
SUB-007 49 F LR6/D Secondary Yes Yes No No Yes No 
SUB-008 20 M UL1 Primary No No No No Yes No 
SUB-009 43 M UR2 Secondary Yes No Yes No No Yes 
SUB-010 57 F LL5 Secondary No No No No Yes No 
SUB-011 36 F LL1 Secondary No No No No Yes No 
SUB-012 35 F UR4/P Secondary Yes Yes No No Yes No 
SUB-013 41 M UR1 Primary Yes Yes Yes No No Yes 
SUB-014 65 F UR1 Primary No Yes No No Yes No 
SUB-015 43 M UR1 Secondary Yes No Yes No No Yes 
SUB-017 26 F UR1 Secondary Yes No No No Yes No 
SUB-018 52 M UR6/D Primary Yes No No Yes No No 
SUB-019 47 F UL2 Primary Yes No No No Yes No 
SUB-020 47 F UL1 Primary Yes No No Yes No No 
SUB-021 50 F UL2 Secondary No No No No Yes No 
SUB-022 50 F UR2 Primary No No No No Yes No 
a: F – female; M – male. b: U-upper, L-lower, R-right, L-left. c: D-distal, P-palatal. d: PL-periodontal ligaments
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 Microbial Culture 
 
3.2.1 Assessment of the presence of viable microorganisms in 
all samples 
Microbial growth (Table 3.2) was observed in over half of the samples 
(21/38: 55.3%). Samples obtained before root canal chemo-mechanical 
preparation procedures (S1) demonstrated the presence of viable 
microorganisms in 78.9% (15/19), while samples collected after the 
completion of root canal chemo-mechanical preparation and medication, 
immediately prior to root canal obturation, (S2) demonstrated viable growth 
in only 31.6% (6/19) of the cases.   
A closer evaluation of infection type, i.e. primary infection or secondary 
infection, showed that growth was detected in 80.0% (8/10) and 77.8% (7/9) 
of S1 samples from primary and secondary infections, respectively.  
S2 samples from primary and secondary infections showed viable growth in 
only 50.0 % (5/10) and 11.0% (1/9), respectively.  
 
Table 3.2: Presence of viable microorganisms in samples from primary 
and secondary infected teeth.  
 
 
All samples Primary  Secondary 
Total S1 S2 S1 S2 S1 S2 
Number in 
which 
growth 
detected/ 
Total 
21/38  15/19 6/19 8/10 5/10 7/9 1/9 
Percentage 
in which 
growth 
detected (%) 
55.3 78.95 31.58 80.0 50.0 77.78 11.11 
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3.2.2 Total microbial loads in S1 samples from teeth with 
primary and secondary infections 
 
Total anaerobic counts from primary infections ranged from 1.7 X101- 7.9 
X106 cfu/ml (mean log10 cfu/ml ± SD: 5.9 ± 1.9), whilst total aerobic counts 
ranged from 3 X103- 4.2 X105 cfu/ml (mean log10 cfu/ml ± SD: 4.7 ± 1.5) 
(Table 3.3 and Figure 3.1). 
The quantity of microorganisms recovered from secondary infections 
ranged from 3 X102- 5 X103 cfu/ml (mean log10 cfu/ml ± SD: 3.3 ± 0.8) and 
from 2.7 X102- 8 X105 (mean log10 cfu/ml ± SD: 5 ± 1.3) with regard to total 
anaerobic and total aerobic viable counts, respectively (Table 3.3 and 
Figure 3.1). 
The differences between the (normalised) mean logarithm values in primary 
and secondary S1 samples were statistically tested using unpaired t-test 
(for independent samples). The differences between total anaerobic 
microbial counts were statistically significant (p=0.012) whereas the 
differences in total aerobic counts were not significant (p=0.789). 
Table 3.3: Total anaerobic and aerobic microbial counts (cfu/ml) in 
primary and secondary S1 samples. 
Sample Microbial 
count 
Number in which  
growth 
detected/total 
(%) 
CFU/ml range Mean 
Count 
cfu/ml 
Minimum   Maximum 
Primary 
S1  
Total 
anaerobic 
7/10 (70.0) 1.7 X 101 7.9 X 106 8.3 X 105 
Total 
aerobic 
7/10 (70.0) 3.1 X 103 4.1 X 105 5.4 X 104 
Secondar
y S1  
Total 
anaerobic 
7/9 (77.8) 3.0 X 102 4.9 X 103 1.8 X 103 
Total 
aerobic 
6/9 (66.7) 2.7 X 102 8.0 X 105 8.9 X 104 
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Figure 3.1:  Total anaerobic and aerobic viable counts (mean log 10 
cfu/ml ± SD) for primary and secondary infections S1 samples. * 
p<0.05 compared with Primary S1. 
 
3.2.3 Growth of specific groups of microorganisms 
 
Examination of selective media from the ten primary infection S1 samples 
(Table 3.4) revealed that the most frequently detected genera or groups of 
organisms were Actinomyces spp. (50%), mutans streptococci (40%) and 
Bifidobacterium spp. (20%) while Lactobacillus spp. and yeasts were only 
observed in one instance. 
 
Table 3.4: Microbial counts (cfu/ml) of specific groups/genera detected 
in primary infection S1 samples.  
Group Number in 
which 
detected/Total 
(%) 
CFU/ml range Mean 
Count 
CFU/ml 
Minimum Maximum 
Actinomyces 
spp. 
5/10 (50.0) 1.2 X 103 2.0 X 104 4.0 X 103 
Bifidobacteriu
m spp. 
2/10 (20.0) 2. X 103 6.3 X 106 6.3 X 105 
Lactobacillus 
spp. 
1/10 (10.0) 3.5 X 103 3.5 X 103 3.9 X 102 
Yeast 1/10 (10.0) 3.0 X 102 3.0 X 102 7.8 X 101 
Mutans 
streptococci 
4/10 (40.0) 1.3 X 102 1.3 X 104 2.1 X 103 
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
Total anaerobic Total aerobic
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On examination of selective media from secondary infection S1 samples, 
Actinomyces spp. were the most prevalent species as it was isolated from 
five out of the total nine secondary cases (55.0%) (Table 3.5).  Mutans 
streptococci and Bifidobacterium spp. were much less prevalent than in 
primary cases as each were only isolated once. Yeasts were not detected in 
the secondary infection samples. Figure 3.2 summarises mean log10 cfu/ml 
± SD counts of the various groups/genera for both primary and secondary 
S1 samples. 
As mentioned above, Actinomyces spp. was the most frequently isolated in 
both primary and secondary infection S1 samples with a range of  1.9 X103- 
2 X104  cfu/ml (mean log10 cfu/m ± SD l: 3.6 ± 1.1) and from 6.7 X101- 1.2 
X103 cfu/ml (mean log10 cfu/ml ± SD: 2.5 ± 0.6), respectively. The difference 
was not found to be statistically significant (p =0.096). It was not possible to 
statistically evaluate the other groups because some values, or the sums 
from equations, were equal or near zero. 
 
Table 3.5: Microbial counts (cfu/ml) of specific groups/genera detected 
in secondary infection S1 samples. 
Group 
Number in 
which 
detected/Total 
(%) 
CFU/ml range Mean 
Count 
CFU/ml 
Minimum Maximum 
Actinomyces 
spp. 
5/9 (55.6) 6.7 X 101 1.2 X 103 3.3 X 102 
Bifidobacterium 
spp. 
1/9 (11.0) 1.7 X 102 1.7 X 02 6.3 X 101 
Lactobacillus 
spp. 
1/9 (11.0) 6.7 X 101 6.7 X 101 5.2 X 101 
Yeast NDa ND ND ND 
Mutans 
streptococci 
1/9 (11.0) 1.0 X 102 1.0 X 102 5.6 X 101 
a. ND – not detected 
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Figure 3.2: Viable counts (mean log 10 cfu/ml ± SD) for the selected 
groups/genera detected in primary and secondary S1 samples. 
(NB groups with no column indicate that organisms were below 
the detection limit of the assay). 
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3.2.4 Effect of root canal chemo-mechanical preparation 
 
 Comparison of microbial counts in all S1 and S2 samples 
 
The total anaerobic counts from S1 samples ranged from 1.7 X101- 7.9 
X106 cfu/ml (mean log10 cfu/ml ± SD: 5.6 ± 1.5), whilst total aerobic counts 
ranged from 2.7 X102- 8.0 X105 cfu/ml (mean log10 cfu/ml ± SD: 4.9 ± 1.4) 
(Table 3.6, Table 3.7, Figure 3.3). 
There was a marked reduction in the quantity of microorganisms in S2 
samples as they ranged from 1.3 X102- 9.5 X103 cfu/ml (mean log10 cfu/ml ± 
SD: 2.7 ± 0.7) and from 2.33 X102- 8.0 X105 (mean log10 cfu/ml ± SD: 5 ± 
1.3) with regard to total anaerobic and total aerobic viable counts, 
respectively. 
The effects of root canal chemo-mechanical preparation in reducing the 
total anaerobic and total aerobic microbial loads were statistically significant 
(p= 0.0001 and 0.004 respectively). 
With regards to the selected groups, Actinomyces spp. were present in over 
half of the 19 cases (53%) with a mean log10 cfu/ml ± SD of 3.36 ± 0.91 
whilst mutans streptococci and Bifidobacterium spp. were present in five 
and three cases with mean log10 cfu/ml ± SD values of : 3.06 ± 0.75 and 
5.52 ± 1.21, respectively. The root canal treatment reduced the prevalence 
to only two cases for each group and the mean log10 cfu/ml values were 
also reduced. The reductions in the mean log10 cfu/ml values were 
statistically significant for Actinomyces spp. and Bifidobacterium spp. (p= 
0.014 & 0.046) but it was not significant for mutans streptococci (p=0.053). 
Figure 3.3 compares the mean log10 cfu/ml values for S1 samples to those 
from S2 and demonstrates the notable reduction in microbial counts in all 
groups. 
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Table 3.6: Microbial counts (cfu/ml) for all S1 samples (primary S1 and 
secondary S1 combined). 
Total microbial 
count or group 
Number in 
which  
growth 
detected/total 
(%) 
CFU/ml range Mean 
Count 
CFU/ml Minimum Maximum 
Total anaerobic 14/19 (73.6%) 1.7 x 101 7.9 X 106 4.4 X 105 
Total aerobic 13/19 (68.4) 2.7 X 102 8.0 X 105 7.1 X 104 
Actinomyces 
spp. 
10/19 (52.6) 6.7 X 101 2.0 X 104 2.3 X 103 
Bifidobacterium 
spp. 
3/19 (15.8) 1.7 X 102 6.3 X 106 3.3 X 105 
Lactobacillus 
spp. 
2/5 (10.5) 6.7 X 101 3.5 X 103 2.3 X 102 
Yeast 1/19 (5.3) 3.0 X 102 3.0 X 102 6.3 X 101 
Mutans 
streptococci 
5/19 (26.3) 1.0 X 102 1.3 X 104 1.2 X 103 
 
 
Table 3.7: Microbial counts (cfu/ml) for all S2 samples (primary S2 and 
secondary S2 combined). 
Total microbial 
count or group 
Number in 
which 
 growth 
detected/total 
(%) 
CFU/ml range Mean 
Count 
CFU/ml Minimum Maximum 
 
Total anaerobic 5/19 (26.3) 1.3 X 102 9.5 X 103 5.2 X 102 
Total aerobic 5/19 (26.3) 2.3 X 102 1.3 X 104 8.2 X 102 
Actinomyces 
spp. 
2/19 (10.5) 6.7 X 101 1.1 X 103 6.4 X 101 
Bifidobacterium 
spp. 
2/19 (10.5) 1.0 X 102 2.0 X 103 1.6 X 102 
Lactobacillus 
spp. 
NDa ND ND ND 
Yeast ND ND ND ND 
Mutans 
streptococci 
2/19 (10.5) 3.3 X 102 8.7 X 102 8.9 X 101 
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a- ND – not detected 
 
 
 
Figure 3.3: Microbial viable counts (mean log 10 cfu/ml ± SD) for all S1 
and S2 samples.  * p<0.05 compared with S1. (NB groups with no 
column indicate that organisms were below the detection limit of 
the assay). 
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the mean log10 cfu/ml ± SD were decreased from 4.7 ± 1.5 to 3.2 ± 1.0 for 
S1 and S2 samples, respectively. However, this reduction was not 
statistically significant (p=0.076). 
In the other selected groups, the reduction in Actinomyces spp. counts had 
a p value of 0.043 which is statistically significant. In contrast, the 
reductions in mutans streptococci and Bifidobacterium spp. were not 
statistically significant as the p values were 0.116 and 0.218, respectively. 
Table 3.8: Total anaerobic, aerobic and the selected groups counts 
(cfu/ml) for primary S1 samples. 
Total microbial 
count or group 
Number in 
which 
growth 
detected/Total 
(%) 
CFU/ml range Mean 
Count 
CFU/ml 
Minimum Maximum 
Total anaerobic 7/10 (70) 1.7 X101 7.9 X 106 8.3 X 105 
Total aerobic 7/10 (70) 3.1 X 103 4.2 X 105 5.4 X 104 
Actinomyces 
spp. 
5/10 (50) 1.2 X 103 2.0 X 104 4.0 X 103 
Bifidobacterium 
spp. 
2/10 (20) 2.4 X 103 6.3 X 106 6.3 X 105 
Lactobacillus 
spp. 
1/10 (10) 3.5 X 103 3.5 X 103 3.9 X 102 
Yeast 1/10 (10) 3.0 X 102 3.0 X 102 7.8 X 101 
Mutans 
streptococci 
4/10 (10) 1.3 X 102 1.3 X 104 2.1 X 103 
 
Table 3.9: Total anaerobic, aerobic and the selected groups counts 
(cfu/ml) for primary S2 samples. 
Total microbial 
count or group 
Number in 
which 
detected/Total 
(%) 
CFU/ml range Mean 
Count 
CFU/ml 
Minimum Maximum 
Total anaerobic 5/10 (50) 1.3 X 102 9.5 X 103 9.5 X 102 
Total aerobic 4/10 (40) 1.9 X 103 1.3 X 104 1.5 X 103 
Actinomyces 
spp. 
2/10 (20) 6.7 X 101 1.1 X 103 7.7 X 101 
Bifidobacterium 
spp. 
2/10 (20) 1.0 X 102 2.0 X 103 2.5 X 102 
Lactobacillus 
spp. 
ND ND ND ND 
Yeast ND ND ND ND 
Mutans 
streptococci 
2/10 (20) 3.3 X 102 8.7 X 102 1.2 X 102 
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 Secondary infections 
There was a reduction in all groups in secondary infection samples both in 
terms of prevalence and microbial loads (Table 3.10, Table 3.11, Figure 
3.4). In fact only one case showed growth above the detection limit in S2 
samples. It was not possible to statistically evaluate the other groups 
because some values, or the sums from equations, were equal or near 
zero. 
Table 3.10: Total anaerobic, aerobic and the selected groups counts 
(cfu/ml) for secondary S1 samples. 
Total microbial 
count or group 
Number in 
which growth 
detected/total 
(%) 
CFU/ml range Mean 
Count 
CFU/ml 
Minimum Maximum 
Total anaerobic 7/9 (77.8) 3.0 X 102 5.0 X 103 1.8 X 103 
Total aerobic 6/9 (66.7) 2.7 X 102 8.0 X 105 9.0 X 104 
Actinomyces 
spp. 
5/9 (55.6) 6.7 X 101 1.2 X 103 3.3 X 102 
Bifidobacterium 
spp. 
1/9 (11.0) 1.7 X 102 1.7 X 102 6.3 X 101 
Lactobacillus 
spp. 
1/9 (11.0) 6.7 X 101 6.7 X 101 5.2 X 101 
Yeast ND ND ND ND 
Mutans 
streptococci 
1/9 (11.0) 1.0 X 102 1.0 X 102 5.6 X 101 
 
Table 3.11: Total anaerobic, aerobic and the selected groups counts 
(cfu/ml) for secondary S2 samples. 
 
Total microbial 
count or group 
Number in 
which 
detected/Total 
(%) 
CFU/ml range Mean 
Count 
CFU/ml 
Minimum Maximum 
Total anaerobic NDa ND ND ND 
Total aerobic 1/9 (11.0) 2.3 X 102 2.3 X 102 7.0 X 101 
Actinomyces 
spp. 
ND ND ND ND 
Bifidobacterium 
spp. 
ND ND ND ND 
Lactobacillus 
spp. 
ND ND ND ND 
Yeast ND ND ND ND 
Mutans 
streptococci 
ND ND ND ND 
a- ND-not detected.
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Figure 3.4 : Microbial viable counts (mean log10 cfu/ml ± SD) for all different samples categories. * p<0.05 compared with 
Primary S1. (NB groups with no column indicate that organisms were below the detection limit of the assay).
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 DNA sample preparation and library results 
3.3.1 Extracted DNA concentrations 
 
The DNA extracts (total of 38 samples comprising 19 S1 and 19 S2 
samples), were quantified using the Quant-ITTM PicoGreen extraction kit, as 
described in Section 2.9.7 (Table 3.12). In a final volume of 200 µl, the mean 
amount of DNA was 56.8ng (range= 1.2- 478.3, SD=94.3). S1 samples 
yielded more DNA than S2 samples with a mean of 88.7 ng (3.6- 478.3, 
123.9) compared to 24.9 ng (1.2- 118.9, 27.6), respectively. The highest 
DNA concentration was observed in Primary S1 samples with a mean of 
92.42 (3.6- 478.3, 138.0). DNA concentration details from individual cases 
are included in Table 3.13. 
 
Table 3.12: Summary of the amount of extracted DNA in ng for all 
sample categories. (The total volume for each sample was 200 μl). 
 Primary 
S1 
Primary 
S2 
Secondary 
S1 
Secondary 
S2 
Mean: 92.4 15.0 84.6 35.9 
Standard 
deviation: 
138.0 14.8 114.4 34.8 
Maximum: 478.3 47.3 375.6 118.9 
Minimum: 3.6 1.2 14.8 4.7 
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3.3.2 PCR and electrophoresis 
 
In order to check that the polymerase chain reaction (PCR) procedures 
(Section 2.9.9) was successful, agarose gel electrophoresis (Section 2.9.10) 
was performed. The gel was visualised using the Bio-Rad Ultraviolet image 
system and the images indicate that vast majority of samples had been 
successfully amplified (Figure 3.5).  
 
 
  
Figure 3.5: Agarose gel electrophoresis for amplified DNAs. A: the 
bottom row relates to the 4 DNA samples that migrated from the well (top 
row). In the other figures 2 rows were used. In C&D the marker (M) occupies 
the 1st column. Note that in B (lane 9) and C (lanes 2 and 13) refer to failed 
samples that were later discarded. 
M   8     9   10  11  12  13 M    8   9    10   11 
M   1    2     3    4   5   6    7 
M    1     2     3    4   5   6    7 
8   9    10   11  12   13 
1     2    3     4   5    6     7 
A 
B 
C D 
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3.3.3 Library size verification: 
 
To achieve the recommended overlap in the pair-end reads, as described in 
Chapter Two and discussed in Chapter Five, the expected size of the library 
DNA amplicon should ideally exceed 490 bp including the linker primers and 
adaptors. This was verified using TapeStationTM. The results (Table 3.13) 
showed that most libraries achieved the recommended size with a mean of 
549 bp (SD=103.2). Figure 3.6 shows the images from the TapeStation and 
Table 3.13 details library amplicon sizes for each sample. From the table 
note that library amplicon size generated in samples 011S2 and 017S2 were 
substantially short (126,127, respectively) and were discarded.   
 
 
3.3.4 Amplicon concentration: 
 
Amplicon concentrations were measured using QubitTM as described in 
Section2.9.14. Table 3.13 shows amplicon concentrations for each sample. 
The mean library concentration was 31.1 ng/µl (SD=20).  
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Figure 3.6: The images from TapeStation library size measurements for 
all samples. The A1 (L) well is occupied by the ladder and the samples 
are in the other wells. Note that the samples in wells C3 & D4 were 
substantially short in size and were later excluded.  
65 
 
Table 3.13: Data summary for the DNA extracts, library size measurement and library 
concentration in tubes prior normalisation.  Note that samples shown in red 
bold italic relate to those excluded at various stages. Table continues overpage. 
Sample ID 
Extracted DNA 
concentration ng/200ml 
Final library size 
in bp 
Library concentration in 
tube ng/µl: 
001 S1 49.28 583 39.2 
001 S2 20.10 607 2.66 
002 S1 121.05 588 33.9 
002 S2 118.89 588 38.7 
003 S1 74.16 514 34.3 
003 S2 34.38 580 14.65 
006 S1 43.07 589 37.1 
006 S2 1.17 509 55.3 
007 S1 375.60 590 18.5 
007 S2 4.67 589 18.6 
008 S1 90.94 580 88 
008 S2 7.89 577 7.83 
009 S1 85.07 584 52.9 
009 S2 27.84 588 88.8 
010 S1 39.62 576 55.4 
010 S2 20.27 558 39.8 
011 S1 35.72 581 35.5 
011 S2 46.69 126 14.9 
012 S1 14.78 571 37.2 
012 S2 9.99 576 20.6 
013 S1 478.30 579 32.5 
013 S2 6.11 578 27.7 
014 S1 64.43 582 26.8 
014 S2 7.29 592 17.75 
015 S1 44.92 506 41.8 
015S2 39.39 591 10.8 
017 S1 22.43 127 0 
017S2 45.08 572 51.3 
018S1 24.87 574 40.1 
018S2 5.83 581 36.1 
019S1 3.63 473 2.14 
019S2 6.83 579 3.21 
020 S1 30.28 585 18 
020 S2 47.33 584 17.1 
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Sample ID 
Extracted DNA 
concentration ng/200ml 
Final library size 
in bp 
Library concentration in 
tube ng/µl: 
021 S1 21.86 586 29.4 
021 S2 10.40 583 35 
022 S1 65.27 576 36.3 
022 S2 13.31 582 20.85 
 
 
 MiSeq sequencing data 
 
3.4.1 Total sequence information  
 
Before proceeding to the final data processing and analyses, preparation of 
the raw MiSeq data files was required in order to allow them to be properly 
handled by QIIME, with the aid of various software packages and 
programmes. These pre-processing steps included removing primer linker 
sequences, re-joining the reads and converting the file fastq to fasta file 
format. These sequences data were then further processed and analysed 
using QIIME, following the instructions provided in the QIIME website 
tutorials (QIIME).  
In total, five clinical samples (011 S2, 017 S1&S2, 019 S1& 019S2) were 
discarded at various stages due to inadequate amplification, short library 
amplicon size and/or poor raw sequencing quality. The remaining 33 
samples passed the quality control process by the MiSeq filtering and QIIME 
pipelines. 
After filtering, a total count of 7,804,376 OTUs were assigned by QIIME 
using the Greengenes database(QIIME), based on a default uclust matching 
(0.97 similarity) with a number of observation of 34,957 (table density, 
fraction of non-zero values=0.209). The average OTUs count per sample 
was 236,496 (+ 84,653) with a range of 88,757 – 541,982. (Table 3.14). 
Also during OTUs de novo picking, uclust constructs a phylogenetic tree 
based on similarities and differences in de novo picked OTUs. The 
phylogenetic tree was constructed as a Newick formatted tree file (.tre) and 
was visualised using FigTree v1.4.2 program (QIIME). This tree was further 
used by QIIME for other analyses.  
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Table 3.14: OTUs count per sample. Note the number of OTUs in the S2 
sample of subject 003 (Bold italic) is substantially more than its 
corresponding S1 sample. This appears to be an outlier. 
 Sample ID No of OTUs (S1) No of OTUs (S2) 
1 001 118722 101094 
2 002 234077   140622 
3 003 162666 541982 
4 006 232654      255910 
5 007 149610      264071 
6 008 234512 88757 
7 009 199041   152637 
8 010 216061   199589 
9 011 254896 Discarded 
10 012 247238     225749 
11 013 244332   233844 
12 014 368848 188708   
13 015 291464   273234 
14 017 Discarded Discarded 
15 018 331011 272242 
16 019 Discarded Discarded 
17 020 305616   184330 
18 021 292914    223177 
19 022 239934   334834 
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3.4.2 Taxonomical identification and abundance 
 Abundance 
 
A total of ten bacterial phyla were assigned by the Greengenes database 
(Figure 3.7). At lower classification levels, 21 different bacterial classes, 35 
orders, 87 families and 143 genera were represented in the root canal 
samples. About 5% of the sequences could not be assigned to phyla level.  
 
 
 
Figure 3.7: Overall abundance at phyla level in all samples. 
     
Overall, the most abundant phyla were Firmicutes (48.6%), Proteobacteria 
(19.1%), Actinobacteria (12.4%), Bacteroidetes (9.2%), and Synergistetes 
(2.0%), Fusobacteria (1.8%) (Table 3.15). Each of the other 4 phyla 
(Spirochetes, Cyanobacteria, Chloroflexi and TM7) corresponded to less 
than 1% of the overall sequences.  
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The three most abundant phyla (Firmicutes, Proteobacteria and 
Actinobacteria) were in the same order of abundance and had similar 
percentages in primary and secondary infections. Bacteroidetes were 
present in about 10.7% in primary infection compared to 7.6% in secondary 
infections. The percentage of Synergistetes (3.4%) and TM7 (1.2%) in 
secondary infections were relatively higher than in primary infections (0.6%, 
and 0.6%) respectively (Table 3.15 and Figure 9). Details according to 
sample and infection type are represented in Table 3.16. 
 
Table 3.15: Abundance of phyla according to infection type presented 
as percentage. 
Taxonomy- Phyla level Total 
abundance 
Primary  Secondary 
Firmicutes 48.6% 49.6% 47.5% 
Proteobacteria 19.1% 17.1% 21.2% 
Actinobacteria 12.4% 13.4% 11.4% 
Bacteroidetes 9.2% 10.7% 7.6% 
Unassigned  5.5% 5.3% 5.8% 
Synergistetes 2.0% 0.6% 3.4% 
Fusobacteria 1.8% 1.9% 1.6% 
TM7 0.9% 0.6% 1.2% 
Spirochetes 0.3% 0.5% 0.1% 
Chloroflexi 0.1% 0.1% 0.1% 
Cyanobacteria 0.1% 0.0% 0.1% 
 
 
 
 
 
 
70 
 
 
 
Figure 3.8: Phyla abundance according to the type of infection. 
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Table 3.16: Bacterial abundance at phyla level in all categories 
presented as percentages. 
 Taxonomy- 
Phyla level 
Primary 
S1 
Primar
y S2 
Secondar
y S1 
Secondar
y S2 
1 Firmicutes 50.5% 49.0% 46.2% 49.2% 
2 Actinobacteria 14.4% 12.6% 11.9% 10.8% 
3 Bacteroidetes 13.9% 8.3% 7.8% 7.3% 
4 Proteobacteria 12.9% 20.3% 17.8% 25.5% 
4 Unassigned  5.2% 5.3% 5.8% 5.7% 
6 Fusobacteria 2.4% 1.6% 2.9% 0.0% 
5 TM7 0.4% 0.8% 1.1% 1.3% 
8 Chloroflexi 0.2% 0.0% 0.1% 0.0% 
9 Cyanobacteria 0.0% 0.1% 0.2% 0.1% 
10 Spirochetes 0.0% 1.0% 0.2% 0.0% 
11 Synergistetes 0.0% 1.0% 6.0% 0.0% 
 
With regards to genera, 143 different genera were found in the chronic root 
canal samples. Table 3.17 displays the most abundant genera and the full 
list of all 143 genera is in Appendix 7. Of these, only 26 were found at an 
abundance of >1% in the overall abundance. 60 % of the top ten genera 
belonged to the Firmicutes phyla.  
Overall, the most abundant (all 33 samples included) were Alkalibacterium 
(7.8%), Bacillaceae (7.7%), Actinotalea (5.5%), Paracoccus (5.2%) and 
Anaerobacillus (4.8%). Interestingly, all of these were more abundant in 
Primary S2 and Secondary S2 samples than in their respective S1 samples. 
Other genera present in the top 30 included Streptococcus, Enterococcus, 
Veillonella, Flavobacterium, Eubacterium, Selenomonas, Pseudomonas, 
Fusobacterium, Actinomyces, Prevotella and Bacillus (Table 3.17 and Figure 
3.9). 
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Table 3.17: The most abundant genera. 
Genera or family level: Overall abundance 
Firmicutes;Alkalibacterium 7.8% 
Firmicutes;Bacillaceae;other 7.7% 
Actinobacteria;Actinotalea 5.5% 
Proteobacteria;Paracoccus 5.2% 
Firmicutes;Anaerobacillus 4.8% 
Proteobacteria;Rhodobacteraceae;other 4.7% 
Firmicutes;Lachnospiraceae;other 3.4% 
Firmicutes;Streptococcus 3.0% 
Firmicutes;Geosporobacter_Thermotalea 2.5% 
Actinobacteria;Rothia 1.9% 
Synergistetes;TG5 1.8% 
Firmicutes;Enterococcaceae;g__Enterococcus 1.6% 
Firmicutes;Veillonella 1.6% 
Bacteroidetes;Porphyromonadaceae;Paludibacter 1.5% 
Bacteroidetes;Cyclobacteriaceae;other 1.5% 
Bacteroidetes;Flavobacterium 1.5% 
Firmicutes;Pseudoramibacter_Eubacterium 1.5% 
Firmicutes;Selenomonas 1.5% 
Proteobacteria;g__Pseudomonas 1.5% 
Firmicutes;Fusibacter 1.4% 
Fusobacteria;Fusobacterium 1.4% 
Firmicutes;Lactobacillales;other 1.3% 
Firmicutes;Clostridiales;other 1.3% 
Proteobacteria;Alkalimonas 1.2% 
Actinobacteria;Actinomyces 1.1% 
Bacteroidetes;Prevotella 1.1% 
Firmicutes;Bacillus 1.1% 
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Figure 3.9: The most abundant genera or family level according to 
infection type (primary or secondary) and sample (S1 or S2). 
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Firmicutes;Marinilactibacillus
Proteobacteria;Rheinheimera
Actinobacteria;Corynebacterium
Actinobacteria;Coriobacteriaceae
Actinobacteria;Slackia
Bacteroidetes;Bacteroidales
Bacteroidetes;Porphyromonadaceae
Bacteroidetes;Cryomorphaceae
Firmicutes;Clostridiales
Bacteroidetes;Fluviicola
Primary S1 Primary S2 Secondary S1  Secondary S2
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Examination of only primary S1 samples (Table 3.19) revealed that the most 
dominant genera were Streptococcus (7.2%), Bacillaceae (5.7%) and 
Eubacterium (5.2%). Other genera such as Prevotella (4.3%), 
Fusobacterium (2.4%), Enterococcus (2.2%) and Actinomyces (1.5%) also 
appeared in the top 20 most abundant genera.  
In secondary S1 samples (Table 3.19), Alkalibacterium (6.8%), Bacillaceae 
(6.6%) and TG5 (6.0%) dominated. Interestingly, the former two genera 
were also the most dominant genera in Primary S2 and Secondary S2 
samples. This may indicate survival properties of these genera. Other 
selected genera such as Fusobacterium, Streptococcus, Actinomyces and 
Enterococcus also appeared in the top 20 most dominant genera in 
secondary infections. 
 
With regards to the number of species level OTUs in each canal (with at 
least 10 taxa per canal) (Table 3.18), the mean number (± SD) was 63 
(±14.9) with range from 34 – 80 and 69.9 (± 12.0) with range from 50 - 87 in 
primary and secondary infections (S1) samples, respectively.  
 
Table 3.18: Species-level OTUs per canal. 
 Primary 
S1 
Primary 
S2 
Secondary S1 Secondary S2 
Mean 63 57.4 69.9 66 
Standard 
deviation 
14.9 15.2 12.0 9.1 
Maximum 80 80 87 77 
Minimum 34 28 50 50 
 
An examination of the heat map also indicated that there was a notable 
degree of inter-individual variation in both taxonomic composition and load 
(Figure 3.10).  
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Table 3.19: The most abundant genera in S1 samples only. 
Genera or family level: PriS1 Genera or family level: SecS1 
Firmicutes;Streptococcus 7.2% Firmicutes;Alkalibacterium 6.8% 
Firmicutes;Bacillaceae 5.7% Firmicutes;Bacillaceae 6.6% 
Firmicutes;Eubacterium 5.2% Synergistetes;TG5 6.0% 
Firmicutes;Lachnospiraceae; 4.9% Actinobacteria;Actinotalea 5.3% 
Bacteroidetes;Prevotella 4.3% Firmicutes;Anaerobacillus 5.1% 
Proteobacteria;Paracoccus 4.0% Proteobacteria;Paracoccus 4.9% 
Actinobacteria;Atopobium 3.3% Proteobacteria;Rhodobacteraceae 4.4% 
Proteobacteria;Rhodobacteraceae 3.0% Fusobacteria;Fusobacterium 2.7% 
Firmicutes;Veillonella 3.0% Firmicutes;Streptococcus 2.6% 
Firmicutes;Anaerobacillus 2.9% Firmicutes:;Thermotalea 2.6% 
Firmicutes;Mogibacterium 2.9% Firmicutes;Fusibacter 2.2% 
Actinobacteria;Actinotalea 2.6% Actinobacteria;Actinomyces 2.1% 
Actinobacteria;Slackia 2.5% Firmicutes;Selenomonas 2.0% 
Fusobacteria;Fusobacterium 2.4% Actinobacteria;Rothia 1.9% 
Firmicutes;Thermotalea 2.3% Firmicutes;Lachnospiraceae 1.8% 
Firmicutes;Selenomonas 2.3% Firmicutes;Veillonella 1.8% 
Firmicutes;Enterococcus 2.2% Bacteroidetes;Paludibacter 1.8% 
Firmicutes;Alkalibacterium 2.0% Bacteroidetes;Flavobacterium 1.5% 
Bacteroidetes;Flavobacterium 2.0% Bacteroidetes;Cyclobacteriaceae 1.4% 
Bacteroidetes;Paludibacter 1.9% Firmicutes;Clostridiales 1.3% 
Actinobacteria;Coriobacteriaceae 1.9% Proteobacteria;Pseudomonas 1.2% 
Actinobacteria;Rothia 1.5% Firmicutes;Mogibacteriaceae 1.2% 
Firmicutes;Lactobacillales;other 1.5% Firmicutes;Enterococcus 1.1% 
Actinobacteria;Actinomyces 1.5% TM7;EW055 1.1% 
Bacteroidetes;Porphyromonadaceae 1.2% Firmicutes;Lactobacillales 1.0% 
Bacteroidetes;Cyclobacteriaceae 1.1% Firmicutes;Bacillus 1.0% 
Proteobacteria;Alkalimonas 1.1% Proteobacteria;Alkalimonas 0.9% 
Bacteroidetes;Bacteroidales 1.1% Firmicutes;Alkaliphilus 0.9% 
Firmicutes;Clostridiales;other 0.9% Proteobacteria;Rheinheimera 0.8% 
Firmicutes;Bacillus 0.8% Proteobacteria;Neisseria 0.8% 
Firmicutes;Lactobacillus 0.8% Firmicutes;Megasphaera 0.8% 
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Figure 3.10: Screenshot of the heatmap. 
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3.4.3 Diversity analyses 
 
 Alpha diversity 
 
In order to assess the diversity within the samples, alpha rarefaction 
diversity was calculated and displayed using the QIIME pipeline (Figure 
3.11, Figure 3.12, Figure 3.13). A steep slope in the rarefaction curve 
indicates that further species richness can be revealed by additional 
sampling. If, however, the curve reaches an asymptote, this means that 
increased sampling efforts are likely to yield no new or only a few additional 
species (Siqueira et al., 2011). 
The diversity analyses of observed species, according to infection type 
(primary or secondary), sample IDs and sample type (S1 or S2), resulted in 
a similar pattern wherein the majority of curves are starting to plateau 
nearing the left side which suggests that further sampling may yield only 
limited additional species.   
 
 
Figure 3.11: Alpha diversity rarefaction curve of observed species (at 
0.3 identity cut off) in primary (red line) and secondary (blue line) 
infections. The curve suggests higher observed species diversity in 
secondary than primary infections. As the curves began to level off, this 
indicates that the diversity has almost been explored for both 
secondary and primary infections. Note that if the lines do not extend all 
the way to the right end of the x-axis, means that at least one of the 
samples in that category does not have sufficient sequences.  
 
78 
 
 
 
 
 
Figure 3.12: Alpha diversity rarefaction curve of observed species (at 
0.3 identity cut off) in all samples. Most curves are starting to plateau 
but not completely which indicates that the diversity was nearly 
explored in most samples. 
 
 
 
Figure 3.13: Alpha diversity rarefaction curve of observed species (at 
0.3 identity cut off) in S1 (red line) and S2 (blue line). 
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 Beta diversity 
 
To assess the diversity between the samples, Beta diversity analysis was 
utilised using QIIME. A 3D PCoA based on weighted uniFrac plot was 
produced with Principal Coordinates PC1, PC2 and PC3 explained at 26%, 
15% and 11%, respectively, of the overall variance among the samples. 
In Figure 3.14, the plots were analysed according to: 
 Sample number. 
 Infection type and sample. 
 Infection type, respectively, from top to bottom. 
The general pattern shows short distances and some clustering of most 
samples, which may suggest that the samples had relatively similar 
microbial diversities. 
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Figure 3.14: Beta diversity weighted uniFrac PCoA plots. Note the 
overall clustering and short distances between the dots apart from 
a few outliers. 
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3.4.4 Jackknifing analysis 
 
Jackknifing analysis is a statistical test used to estimate the bias and 
standard error (variance) and so here it basically measures the robustness 
of the sequencing effort. In jackknifing analysis, a small number of 
sequencing data were chosen at random from each sample, and the 
resulting tree from this subset of data was compared with the tree 
representing the entire data set. This produced a 3D PCoA based on 
weighted uniFrac calculator with Principal Coordinates PC1, PC2 and PC3 
explained at 26%, 15% and 11% of the overall variance among the samples, 
respectively (Figure 3.15). In addition, during this process, master and 
jackknifed trees were also produced (Figure 3.16 and Figure 3.17). 
The general pattern of clustering of the vast majority of the examined 
samples in all three plots, analysed according to sample number, infection 
type and sample & infection type, respectively, from top to bottom as  shown 
in Figure 3.15, indicates the sequencing effort used in this study was 
efficient and robust (QIIME).  
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Figure 3.15: Jackknife weighted uniFrac PCoA plots. Note the overall 
clustering of dots apart from a few outliers. 
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Figure 3.16: The master tree produced by jackknifing analysis. 
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Figure 3.17: Jackknifed tree produced by the jackknifing analyses. 
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3.4.5 Microbial associations between samples 
 
Using the OTUs table generated during the processing of data, scripts were 
constructed in QIIME to compute the shared OTUs at species level between 
the various samples. The output, generated as a text file, was then 
rearranged in Microsoft excel worksheet to compare primary and secondary 
S1 samples as described below. 
 
 Shared OTUs between Primary and secondary infection 
samples (S1) 
 
Comparisons were drawn between primary and secondary S1 samples 
(Table 3.20). The mean percentages of shared OTUs between primary and 
secondary S1 samples were approximately 40% with a range from 18 % - 
60%. Consequently, it is possible to state that less than half of the number of 
OTUS were shared between the samples.   
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Table 3.20: Shared OTUs (at species level) between S1 samples from primary (red) and S1 samples from secondary (black) 
infection. Figures above the blank diagonal line relate to the number of shared OTUs and the percentages are below the 
blank line. 
 S0221 S0211 S0131 S0081 S0151 S0181 S0021 S0201 S0061 S0121 S0101 S0071 S0091 S0111 S0031 S0011 S0141 
S0221   4408 2554 3585 3806 4574 4683 4139 3896 2941 4244 3099 3861 2068 3193 3100 2186 
S0211 57%   2869 4096 4768 5228 5016 5251 4413 3662 5012 3399 4808 2166 3285 3509 1761 
S0131 33% 33%   3051 2890 3057 3005 3031 2549 2748 2886 2105 3034 2196 2543 2558 1596 
S0081 46% 47% 54%   3765 4238 4343 4031 3679 2996 4111 2821 4006 2039 3123 3113 1663 
S0151 49% 55% 51% 51%   4860 4562 4980 3830 3616 4551 2868 4453 2318 3125 3204 1693 
S0181 59% 60% 54% 58% 57%   5856 5140 4446 3467 5091 3346 4884 2283 3531 3656 1714 
S0021 60% 58% 53% 59% 53% 62%   4949 4927 3321 4900 3627 4598 2256 3634 3697 1729 
S0201 53% 60% 54% 55% 58% 55% 50%   4479 4249 4866 3311 4659 2397 3194 3421 1768 
S0061 50% 51% 45% 50% 45% 47% 50% 49%   3199 4315 3543 4301 2244 3317 3288 1588 
S0121 38% 42% 49% 41% 42% 37% 34% 46% 41%   3594 2473 3473 2445 2593 2515 1721 
S0101 55% 58% 51% 56% 53% 54% 50% 53% 55% 59%   3265 5240 2489 3659 3376 1631 
S0071 40% 39% 37% 38% 34% 36% 37% 36% 45% 41% 35%   3093 1675 2516 2628 1354 
S0091 50% 55% 54% 54% 52% 52% 47% 51% 54% 57% 56% 59%   2331 3719 3514 1590 
S0111 27% 25% 39% 28% 27% 24% 23% 26% 28% 40% 27% 32% 26%   2031 1773 1432 
S0031 41% 38% 45% 42% 37% 38% 37% 35% 42% 43% 39% 48% 42% 35%   3359 1554 
S0011 40% 40% 45% 42% 37% 39% 38% 37% 42% 41% 36% 50% 40% 31% 50%   1404 
S0141 28% 20% 28% 23% 20% 18% 18% 19% 20% 28% 18% 26% 18% 25% 23% 21%   
 
 
87 
 
 
 
3.4.6 Effect of root canal treatment on OTUs numbers 
 
The number of OTUs detected in each sample, as shown in Table 3.14, was 
used to compare the effect of treatment on primary and secondary infections. 
Overall, the average number (± SD) of OTUs detected in S1 samples was 
242,564 (+ 64,250) OTUs/sample compared to 209,253 (+ 68,323) in S2 
samples. Table 3.21 provides summaries for each category. The effect is also 
illustrated using box and whisker plot (Figure 3.18).  
 
Table 3.21: Number of OTUs detected from samples according to the 
category.   
 
Number of OTUs  
Primary S1 Primary S2 Secondary S1 
Secondary 
S2 
Mean 248699 207465 235663 211297 
Standard 
deviation 
78502 84308 47851 50899 
Minimum 
 
118722 88757 149610 140622 
Maximum 368848 334834 292914 273234 
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Figure 3.18: Box and whisker plot comparing the number of sequencing 
reads from all four categories. The top and bottom boundaries from the 
boxes show the 75th and 25th percentile and the end of the whiskers show 
the maximum and minimum values. The line within the box represents the 
median values (50th percentile). Note this plot was constructed after 
removing one outlier from primary S2 category. 
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Chapter 4 Conclusions 
 
 High throughput sequencing on MiSeq managed to explore the diverse 
endodontic microbiology in particular low abundance species. 
 
 Root canal infections are more diverse than previously demonstrated by 
culture and most molecular techniques. 
 
 Contrary to previous indications, chronic secondary infections have 
similar diversity to chronic primary infections. 
 
 Some species seem to be able to survive the standard root canal 
disinfection procedure. 
 
 Strict aseptic procedures, more potent disinfection technique, irrigation 
and washing time may be recommended.  
 
 Further studies are essential to further explore the diversity as well as 
the understanding the ecology within the infected root canal and apical 
regions.  
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Chapter 5  Discussion 
 The study design and methodology 
5.1.1 Study population 
 
The participants of this study consisted of patients with clinical and/or 
radiographic evidence of root canal infections. An important inclusion criterion 
was tooth restorability which is a requirement for root canal treatment 
(European Society of Endodontology, 2006). The opportunity to treat a 
restorable tooth and complete the treatment allowed us to obtain post chemo-
mechanical preparation samples. Another important inclusion requirement was 
the absence of advanced or active periodontal disease. This is because of the 
known intimate relationship and communications between the pulp and 
periodontal space. The possible contamination of the root canal via periodontal 
microorganisms in advanced periodontal disease has been demonstrated 
previously (Kipioti et al., 1984; Kobayashi et al., 1990).  
Routine root canal treatment is not contraindicated for most 
immunocompromised patients. However, because of possible health reasons, 
altered host response to treatment and the possible need for antibiotics, these 
patients were excluded from the study. Similarly, patients who were pregnant 
and those under 18 years of age, were excluded due to patient convenience 
and because it was ethically less acceptable to include such vulnerable 
individuals in a study of this type. 
With regards to use of systemic antibiotics, over the years there has been a 
controversy surrounding this subject. Some researchers reported reduction of 
some species after the use of various forms of systemic antibiotic therapy 
(Haapasalo et al., 1983; Yamamoto et al., 1989). More recently, however, 
questions about the actual benefit of antibiotics for most endodontic cases, and 
concerns over bacterial resistance, have encouraged many authors to 
advocate strict and careful use of systemic antibiotics (Longman et al., 2000).  
For this study, although the intra-radicular effect of antibiotics, should be 
extremely minimal, if any, especially in areas devoid of blood supply, such as 
the necrotic pulp, no risk, however minimal, was taken by including patients 
with recent antibiotic use.  
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Teeth with posts were also excluded from the study for several reasons: they 
would need to be removed to complete the root canal retreatment, and the 
removal procedures usually prolong the treatment. The removal procedures 
also bring higher risks of a number of complications, such as root or post 
fracture and perforation. In addition, in these cases it can be more difficult to 
ensure complete seal between appointments and in case of the provision of a 
temporary post, the additional surfaces of the post may even provide another 
challenge with sterilisation, canal contamination and act as a potential platform 
for microbial growth. Other exclusion cases included dental anomalies such as 
dilacerations, evidence of canal calcifications and severe root curvature 
because they present a huge challenge to microbiological sampling with paper 
points.  
 
5.1.2 Sample size 
 
The sample size of this pilot study was determined following statistical advice 
by a qualified biostatistician at the Centre of Epidemiology and Biostatistics, 
University of Leeds.  
As mentioned previously, none of the Illumina technologies sequencing tools 
had been used to investigate endodontic microbiology at the start of this project 
(July 2012), although at that time some other human body meta-genomic 
studies were published. There are significant differences in the anatomy, 
ecosystem, infection nature and disease pathogenesis when comparing the 
root canal system and other body sites. Consequently, these studies were not 
appropriate to use for statistical calculation of a sample size and hence a 
decision was made to conduct a pilot study. There were, however, three 
studies that used a similar NGS technique in the form of pyrosequencing (Li et 
al., 2010; Siqueira et al., 2011; Santos et al., 2011) and the sample sizes used 
were 7, 10 and 17 participants. The usual pilot study with a sample size of 30 
does not apply here because our observed outcome was not expected to be 
normally distributed data. Therefore, based on this, previous literature and the 
time available for patient recruitment and sampling, we proposed to recruit 20 
participants with an expected dropout rate of ˂15 %.    
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5.1.3 Microbiological sampling methodology 
 
To investigate the microbiota of root canal infections in its natural habitat, the 
most common approaches are:  
 Nonsurgical endodontic approach. 
 Surgical endodontic approach, or 
 The use of freshly extracted teeth. 
The selection of a specific approach or methodology is determined by the 
primary and secondary questions being posed and this in turn generally 
dictates the microbiological sampling method.  
A non-surgical approach during ortho-grade root canal treatment provides 
access to the root canal space through the clinical crown. One important 
advantage of this method is that the crown can be properly isolated from the 
oral environment using rubber dam, clamp and sealing agents which allow for 
superior operating site decontamination and reduce the likelihood of sample 
contamination. Also, using this method, more than one sample can be obtained 
on different occasions to, for example, assess disease changes and host 
response. Paper points are the most traditional and widely used method to 
collect samples from within the root canal space (Fouad, 2009). Sometimes an 
endodontic file is used to break up the biofilm and the file may be included in 
the sample, as was done in this study. Moller performed several 
comprehensive methodological experiments in this regard, the majority of 
which are still valid (Moller, 1966). A major drawback of using paper points, 
however, is that it does not permit the distinction of the root canal portion that is 
sampled (apical, middle, coronal), nor it is able to access hard to reach areas, 
such as isthmus and ramifications, which can also harbour bacteria (Siqueira et 
al., 2010). 
A surgical endodontic approach is used to gain direct access to the apical 
region through the soft and hard tissues. This constitutes an advantage over 
the use of conventional paper points as it gives direct access to the 
anatomically complex root apex as well as the enclosed apical lesion, allowing 
for a comprehensive analysis of this vitally important area, which is not possible 
via the nonsurgical approach. A historic accusation of this approach is 
concerned with the possible contamination of the periapical lesion during the 
reflection of the mucosal  flap and microbial sampling (Fouad, 2009). However, 
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Sunde et al. (2000) surgically examined 30 root filled teeth with apical pathosis. 
They concluded that when care is taken during disinfection procedures, site 
contamination appeared to be very minor. Another limitation is that this 
approach can only be appropriate for selective analysis of apical infections. 
Also, because the revision of surgical approach is only indicated for limited 
cases, multiple samples cannot be normally obtained. 
Unhindered by anatomical constraints, extraction of teeth provides direct 
access to the root canal and root surface. Sectioning of extracted teeth and   
analysing cryogenically-ground samples has a big advantage over the other 
two approaches as it allows the investigation of various, distinct segments of 
the root canal systems (Rocas et al., 2010). However, contamination of the root 
from the periodontium and oral environment during tooth extraction is always a 
concern. This approach does not allow for the opportunity to longitudinally 
study disease progression. 
Taken together, there is no one perfect approach for endodontic microbiological 
sampling and no method is without its inherent limitations, including the use of 
paper points. Nonetheless, paper points remain the most common method and 
the most appropriate option to answer the defined aims and objectives of this 
study. Further efforts are certainly required to develop more accurate 
endodontic sampling techniques or devices.  
 
5.1.4 Root canal treatment procedures 
 
As for the clinical treatment, it is always essential to provide patients with the 
best agreed practice and care. The root canal treatment procedures of this 
study were tailored to achieve this aim as well as to optimise the quality of the 
study in accordance with the ethics and regulations of the UK. Although the 
study population sample selected for this project was of a chronic nature, the 
definitive diagnoses varied and, hence, some details of the treatment needed to 
be tailored for each given case. In addition, other factors such as tooth 
morphology, the restorative status or those related to the patient were vital 
when judging the most appropriate treatment choice. Despite all of this, the 
clinical protocol was designed to be as similar as possible for all patients. This, 
in addition to collection of samples at exact time intervals, was aimed to obtain 
a more comparable, reflective picture of the microbiological status of the 
infected root canals.    
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One of the secondary objectives of this study was to investigate the microbial 
status of infected root canal after chemo-mechanical preparation. Opting for a 
multiple root canal treatment visit-approach allowed for this investigation as 
well as for comparison with pre-preparation samples. Although a Cochrane 
Review detected no significant differences in the effectiveness of root canal 
treatment between single and multiple visits, it concluded that the former is 
associated with higher frequency of symptoms (Figini et al., 2008).  In addition,  
for teeth with necrotic pulps and apical disease, as in this study, multiple visit 
root canal treatment is the traditional treatment option as it allows the use of 
inter-appointment medication which may be beneficial for the cases with more 
established infections (Sathorn et al., 2009). 
The adoption of aseptic methods is mandatory for the success of the treatment 
and an absolute necessity for the validity of the research (Fouad, 2009) . 
Aseptic techniques include wearing sterile surgical gloves for sampling, 
sterilisation of instruments and the use of rubber dam (European Society of 
Endodontology, 2006). In secondary cases, the removal of old root filling was 
performed mechanically except for two cases. Minimal solvent was applied to 
complete the removal of remaining root filling. This might have exerted some 
negative effect on the microbiota but it was vital to avoid jeopardizing the 
treatment outcome.  
Although a mere manual instrumentation with sterile saline can reduce the 
number of bacteria in the canal by 100 to 1000 fold (Bystrom and Sundqvist, 
1981), clinicians are expected to use an irrigant with antimicrobial properties 
(European Society of Endodontology, 2006). Sodium hypochlorite has been 
advocated as the irrigant of choice for most cases (Eliyas et al., 2010). Its  
broad antimicrobial spectrum and other favourable properties such as tissue 
dissolving abilities, viscosity and low cost have been thoroughly reviewed 
(Mohammadi, 2008). The efficacy of NaOCl depends on many factors such as 
concentration, temperature, volume and contact time (Zehnder, 2006) . Various 
concentrations of NaOCl are in use ranging from 0.5% to full strength 5.25% (or 
6% in US) but it remains a controversial issue. Generally, higher concentrations 
reduce microbes and dissolve necrotic tissues in less time, volume and 
temperature than lower concentrations. However, high NaOCl concentrations 
are extremely toxic and can cause severe complications (Eliyas et al., 2010).  A 
concentration of 2.5% was used in this research which properly provides a 
balance between effectiveness and safety. 
 Calcium hydroxide was used as an inter-appointment intracanal medication. 
Since its first dental application in the 1920s, it is still the most commonly used 
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endodontic medication throughout the world. This is because of its well 
documented and researched antibacterial, physical and biological properties 
(Athanassiadis et al., 2007).  
In the vast majority of cases, lateral compaction was used which is still the 
most widely used and taught technique of filling  root canals, because it is 
simple, relatively cheap and can result in well-adapted root fillings (Patel and 
Barnes, 2011). 
 
5.1.5 Tooth surface decontamination 
 
Decontamination of the sampling field is a mandatory measure for correct 
sampling and to avoid false-positive results during microbiological analysis. 
Traditionally, the protocol recommended by Moller (1966) using 30% hydrogen 
peroxide followed by 5% or 10% iodine tincture has been considered as the 
gold standard. More recently Ng et al. (2003) compared the effect of 10% 
iodine tincture to 2.5% sodium hypochlorite (NaOCl) on the microbiota in vivo 
using culture and PCR. Analyses revealed no significant differences between 
them as decontaminating agents when microbial culture methods were used for 
detection. However, PCR showed that NaOCl was more effective as a tooth 
surface decontaminating agent than iodine. In our study, we used the later 
protocol with some modification by using a combination of 3% hydrogen 
peroxide and 2.5% NaOCl as described by other groups (Siqueira et al., 2004; 
Sakamoto et al., 2008). 
 
5.1.6 The 16S rRNA gene and variable target regions as a bacterial 
identification tool 
 
Metagenomic studies are commonly performed by analysing the prokaryotic 
16S ribosomal RNA gene (16S rRNA) sequence. The 16S gene is ubiquitous in 
all bacteria and its main advantage is that it is long enough to be highly 
informative but also short enough to be easily sequenced (Fouad, 2009). The 
16S rRNA gene consists of approximately 1,500 bp and contains nine variable 
regions (V) interspersed between conserved regions. Variable regions of 16S 
rRNA are frequently used in phylogenetic classifications. However, the choice 
of which variable region is open to debate because it depends on several 
factors such as experimental objectives, design, and sample type (Kuczynski et 
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al., 2012). Due to the high diversity of bacteria, it may be more desirable to 
target more than one variable region to increase sensitivity, specificity and 
reliability of the 16S gene study (Wahl et al., 2013b). Consequently, this study 
opted to use the V3 and V4 regions. An experimental study showed that 
targeting this region yields high quality sequencing data (Fadrosh et al., 2014). 
This is also recommended in the Illumina protocol manual (Illumina, 2013).  
Moreover, and in order to ensure high quality microbial classification, the study 
aimed to sequence two variable regions and to obtain paired-end reads of 
approximately 490 bp length with about 50 bp overlap. The primers used for 
amplification were 347F/803R which have been shown to be a suitable primer 
pair for classification of complex human microbiome (Nossa et al., 2010). 
 
 Study results 
 
5.2.1 Culture 
 
Microbial growth was observed in 80% and 77.8% of samples from primary and 
secondary infections, respectively. In contrast, previous culture studies 
demonstrated that secondary infections are associated with fewer positive 
cultures than primary infections (Baumgartner, 2004).  It was observed that in 
primary infections, anaerobes dominated whereas in secondary infections, total 
facultative and aerobic counts were more dominant. This may indicate that 
there are significant differences in the microbiomes derived from primary and 
secondary infections. This is agreement with previous studies (Bystrom and 
Sundqvist, 1981; Kvist et al., 2004; Gomes et al., 2004; Baumgartner, 2004).  
Actinomyces spp. are usually detected in apical lesion infections 
(Ramachandran Nair and Schroeder, 1984). Molecular studies demonstrated 
that they are also found in dental caries lesions (Aas et al., 2008). In root canal 
infections they have been isolated in both primary and secondary infections 
(Sjogren et al., 1997; Tronstad and Sunde, 2003). Molecular studies showed 
that Actinomyces spp. were detected in 72 of 129 (55.8%) clinical samples (Xia 
and Baumgartner, 2003). In our study, Actinomyces spp. seem prevalent 
among the studied groups. They were detected in 50% and about 56% in 
primary and secondary S1 samples. However, there was a marked reduction in 
S2 samples as it was only detected in two out of the total 19 S2 samples. This 
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suggests that they may have survival properties. Findings from NGS also 
indicated that Actinomyces spp. is amongst the most prevalent genera. 
Streptococcus spp. are also commonly found in the oral cavity (Aas et al., 
2005) and are traditionally mainly associated with dental caries (Aas et al., 
2008). It has been repeatedly isolated from both primary and secondary root 
canal infections (Abou-Rass and Bogen, 1998; Khemaleelakul et al., 2002; 
Mindere et al., 2010) and in this study it was observed in four out of the ten 
primary S1 samples and in only one of the nine secondary S1 samples. The 
ability of streptococci to survive root canal treatment has been previously 
reported (Chavez De Paz et al., 2003). Findings from the culture experiments 
showed only two S2 samples containing Streptococcus spp. 
 
5.2.2 Sequencing  
 
Since NGS became available, there have been great advances in various 
aspects of the technology. Several metagenomics studies have been carried 
out in various fields such as environmental (Wahl et al., 2013b), nutrition (Wahl 
et al., 2013a), animals (Sturgeon et al., 2014; Moreau et al., 2014) and humans 
(Kong, 2011; Hattori and Taylor, 2009; Kistler et al., 2013). Indeed, all of these 
studies, and many others, have revealed that microbial diversities in these 
environments were of magnitudes higher than previously described.  
As mentioned previously,  at the time this study was proposed (September 
2012), to our knowledge, only six endodontic metagenomic studies had been 
published (Li et al., 2010; Siqueira et al., 2011; Santos et al., 2011; Saber et al., 
2012; Ozok et al., 2012; Lim et al., 2011). Since then further four studies have 
been published (Hong et al., 2013; Anderson et al., 2013; Vengerfeldt et al., 
2014; Tzanetakis et al., 2015). The sample sizes used in these studies were 6, 
7, 10, 12, 13, 17, 18, 23, 40 and 48. Five studies examined in vivo primary and 
secondary infections (Hong et al., 2013; Tzanetakis et al., 2015; Lim et al., 
2011; Li et al., 2010; Vengerfeldt et al., 2014), three studies investigated apical 
regions in extracted teeth (Siqueira et al., 2011; Saber et al., 2012; Ozok et al., 
2012) , one compared chronic to acute primary infections (Santos et al., 2011) 
and the final one studied secondary infections (Anderson et al., 2013).  
The primary goal of this study was to investigate the microbial diversity of 
primary (previously untreated) and secondary (previously filled) root canal 
infections.  Although the clinical parameters of the endodontic infections 
included in this study were of a chronic nature, it was a relatively diverse 
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sample in terms of infection type, i.e. primary or secondary, stage of disease 
and clinical symptoms. However, the emphasis was on the “depth of coverage” 
that results from the use of NGS compared with a traditional method, in the 
form of culture, in analysing these infections. 
From the initial 38 samples, 33 samples (including S1 and S2 samples) were 
used to carry out library preparation and sequencing procedures.  Overall, the 
analysis detected a total of ten bacterial phyla while about 5% of the sequences 
could not be assigned to phyla level. At lower levels, 21 different bacterial 
classes, 35 orders, 87 families and 143 genera were represented by the root 
canal samples. A comprehensive review of findings from previous culture and 
molecular studies, prior to 2009, demonstrated that more than 460 bacterial 
species/ phylotypes belonging to 100 genera and 9 phyla have been detected 
in the different types of endodontic infections (Siqueira and Rocas, 2009a). The 
findings from our study alone suggest that these numbers may be 
underestimated. This is also supported by previous NGS studies. Using 
pyrosequencing, 13 bacterial phyla and 179 genera were detected in only 
seven teeth (Li et al., 2010) while in the apical root canal infections, there were 
84 genera and 10 phyla (Siqueira et al., 2011). Ozok et al. (2012) studied 23 
extracted teeth and compared apical and coronal segments and in total they 
detected 24 phyla. Each of the other seven NGS studies detected between 9 -
13 phyla (Hong et al., 2013; Anderson et al., 2013; Vengerfeldt et al., 2014; 
Tzanetakis et al., 2015; Lim et al., 2011; Santos et al., 2011; Saber et al., 
2012). 
Regarding the unassigned phyla, about 5% were unclassified, which may be 
considered slightly high at the phylum level. This may be due to PCR artefacts, 
sequencing errors or possibly unknown bacterial phyla (Santos et al., 2011). 
A detailed examination of primary and secondary S1 samples revealed notable 
differences. The most dominant phyla in primary S1 samples were Firmicutes 
(50.5%) followed by Actinobacteria (14.4%) and Bacteroidetes (13.9%). While 
secondary infections were dominated by Firmicutes (46.2%), Proteobacteria 
(17.8%), Actinobacteria (11.9%), and Bacteroidetes (7.8%).  
Firmicutes was also the dominant phylum in primary and secondary infection in 
a study that utilised the Illumina HiSeq2000 instrument (Vengerfeldt et al., 
2014). Other studies comparing primary and secondary infections revealed 
different findings. Firmicutes seem to dominate secondary infections (Anderson 
et al., 2013), while Bacteroidetes were the most abundant phylum in both 
primary and persistent infections. 
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These differences in the dominant phyla and/or genera might be due to several 
aspects. These include the different clinical conditions and anatomical 
locations, different methods used for sampling, different NGS technologies and 
the use of different reading lengths. In addition, geography-related differences 
in the endodontic bacterial communities cannot be discounted as a possible 
cause for differences (Machado de Oliveira et al., 2007; Siqueira et al., 2008). 
At the genus level, the most dominant in primary S1 sample were 
Streptococcus, Bacillaceae (5.7%) and Eubacterium (5.2%). Prevotella (4.3%), 
Fusobacterium (2.4%). Enterococcus (2.2%) and Actinomyces (1.5%) 
appeared in the top 20 most abundant genera. The Streptococcus genus was 
the most dominant in a number of culture, molecular and pyrosequencing 
studies (Rocas et al., 2010; Siqueira et al., 2002; Rocas et al., 2008; Anderson 
et al., 2013). 
On the other hand, the most dominant genera in secondary S1 samples were 
Alkalibacterium (6.8%), Bacillaceae (6.6%) and TG5 (6.0%). Interestingly, the 
former two genera were also the most dominant genera in Primary S2 and 
Secondary S2 samples. This may indicate survival properties of these genera. 
Other selected genera such as Fusobacterium, Streptococcus, Actinomyces 
and Enterococcus also appeared in the top 20 most dominant genera in 
secondary infections. 
Alkalibacterium is an alkaliphilic bacterium isolated from marine organisms, 
salted foods, soft semi-hard cheese and edible-olive wash-waters (Ntougias 
and Russell, 2001; Ishikawa et al., 2013). To our knowledge, this has not been 
previously isolated from endodontic infections. However, the detection of this 
species in this study should undergo further investigation. Although 
Alkalibacterium could have gained access to the root canal system via the oral 
cavity, through for example diet, it is important to exclude other possibilities 
such as sequencing errors. To exclude the latter, an experiment could be 
carried out using PCR with specifically designed primers to detect 
Alkalibacterium. Unfortunately, no further samples remained to conduct this 
verification experiment.  
The Synergistes are a group of Gram-negative anaerobic organisms that have 
been frequently found in the oral cavity (Vartoukian et al., 2007) as well as in 
endodontic infections (Siqueira and Rocas, 2005c). In this study, relatively 
abundant Synergistes spp. (6%) were identified in secondary infections, 
indicating that they may be an important member of the microbiota of teeth with 
failed root canal treatment.  
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Spirochete spp. are free-living, facultative, or obligate anaerobes, often found in 
ponds and marshes (Paster and Dewhirst, 2000). In this study they were 
detected in secondary infections but with low abundance. Pyrosequencing also 
detected Spirochete in Li et al (2010). 
Prior to NGS studies, Cyanobacteria, Acidobacteria, and Chloroflexi, which are  
known bacterial phyla in water, soil, and wastewater plants, respectively, had 
not been detected in endodontic infections (Li et al., 2010). Most of these were 
rather in low abundance and may have passed unnoticed in previous 
endodontic culture and molecular studies. 
Enterococcus has been described as the most frequently detected bacterium in 
root-filled teeth with infections (Cheung and Ho, 2001). In the present study, 
Enterococcus genus appeared in the top 20 genera and constituted 2.2% and 
1.1% from primary and secondary, respectively. The Enterococcus genus was 
detected as a low-abundance (0.7%) genus of secondary endodontic infections 
in the pyrosequencing study by Hong et al. (2013) whereas in Anderson et al. 
(2013) it was among the 15 most abundant genera (2.59%).  
Contrary to early studies which advocated a vital role of E. faecalis in 
secondary infections (Portenier et al., 2003), more recent studies have 
questioned that belief because it had not been detected or is rarely one of the 
most dominant species in root canal–treated teeth  (Rocas et al., 2004; Chugal 
et al., 2011).  
With regards to the number of species-level OTUs per canal, the mean number 
of species-level taxa in each canal was 63 (range from 34 – 80) in primary 
infections and 69.9 (range from 50 – 87) in secondary infections. Siqueira et al. 
(2011) reported a mean number of about 37 species-level taxa (range13-80) in 
the apical canal, whereas Ozok et al. (2012) reported a mean of 125 taxa (70-
185) per canal. These figures are much higher than the average 3–5 species 
demonstrated by culture studies (Sundqvist, 1992; Siqueira et al., 2007) and 
the 10–20 species per canal revealed by previous molecular analyses of 
samples taken from the main canal with no distinction of the sampling site 
(Munson et al., 2002; Siqueira et al., 2004; Siqueira et al., 2008).  
In terms of composition, examination of the heat map showed a marked inter-
individual variability in the composition of bacterial communities. Each 
individual harboured a unique endodontic microbiota in terms of species 
richness and abundance. This was also evident between primary and 
secondary samples as demonstrated by shared OTUs percentages, which 
showed that in most samples the similarity level was less than 50%. The fact 
that the composition of microbiota differs consistently within and between 
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individuals with the same disease denotes a heterogeneous aetiology for apical 
periodontitis, where multiple communities can lead to similar disease 
outcomes. Despite this inter-individual variability, according to the weighted 
unifrac beta diversity analyses, many samples showed a tendency to cluster 
together. This suggests that some patterns of community structures may exist 
and these might be related to distinct clinical conditions. 
Although alpha diversity analyses suggested that the diversity is nearly 
explored in the study, one must consider that the use of paper points in the 
present study may not be optimal to sample the whole microbiota in the 
complex root canal systems including dentinal tubules, isthmus, and lateral 
(accessory) canals, especially at apical third areas. This indicates that the 
overall bacterial diversity in both endodontic infections may be considerably 
higher than currently identified. 
 
5.2.3 The effect of chemo-mechanical preparation and medication 
on the endodontic microbiota 
 
The main goals of root canal treatment is to eradicate the microbial infection, or 
at least to reduce it to a level compatible with healing, and to prevent future re-
infection of the root canal system (Sjogren et al., 1997). It should be reiterated 
that evaluating the effect of the standard root canal chemo-mechanical 
preparation and medication procedures was only a secondary objective in this 
study.  
Using microbial sampling to assess the microbial composition and load 
changes before and after treatment is referred to as a surrogate outcome. The 
method is certainly not an accurate method to predict treatment outcome but it 
may provide indications. Indeed, culture studies in the 1970s and 1980s 
advocated its use for clinical evaluation of treatment outcome (Fouad, 2009). 
Long term prospective cohort studies are more accurate in assessing treatment 
outcome. Yet, they still suffer from several patient and clinical confounding 
factors as well as clinician/ researcher bias.  
In this study, culture S2 samples showed marked reductions in viable microbial 
load especially in secondary infection cases. Complete periapical healing 
occurred in 94% of cases that yielded a negative culture. Where the samples 
were positive prior to root filling, the success rate of treatment was just 68% 
(Sjogren et al., 1997). 
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On the contrary, the NGS analysis outputs demonstrated that there was no 
significant difference in OTUs loads before and after root canal treatment. This 
may be explained by the fact that molecular techniques do not differentiate 
DNA from live or dead microorganisms. This finding emphasizes the current 
knowledge that existing root canal preparation procedures usually fail to 
disinfect and clean large parts of the root canal system (Siqueira, 2001) . The 
presence of high loads of OTUS in S2 samples may hold clinical implications. 
These OTUs may be the genetic material from dead species. Some 
components from these dead species remaining in the canal may serve as 
nutrition for surviving or, future, invading microorganisms leading to persisting 
or recurring infections. Moreover, other remnants of bacterial cells may be 
involved in inflammatory reactions. 
Another interesting observation is that the sequencing analyses of S2 samples 
showed some genera that had not appeared in the primary samples. This could 
be simply because paper points failed to pick up these species in the S1 
samples. The other probable explanation is that these microorganisms may 
have been hidden in the dentinal tubules, as some microbes are able to 
colonise dentinal tubules (Siqueira et al., 1996), and only appear after being 
exposed by root canal wall instrumentation. Other reasons might be canal 
contamination during or between treatment visits, environmental contamination 
or sequencing errors.    
As noted earlier, it was interesting to observe that the genera Alkalibacterium 
and Bacillaceae were the most dominant in Primary S2, Secondary S1 and S2 
samples. This may indicate that some species of these genera are more 
difficult to remove from infected root canals. To our knowledge, this have not 
been previously isolated from endodontic infections.   
 
5.2.4 Limitations of NGS 
 
Another shortcoming of DNA based studies is the inability to discriminate dead 
from live microorganisms and hence all genetic material is assessed (Siqueira 
and Rocas, 2005a). This may overestimate bacterial load because it has been 
reported that DNA can persist for up to one year after cell death (Young et al., 
2007). It is argued, however,  that an assessment of both live and dead 
microorganisms is important because these bacteria may have been 
predominant in the early phases of disease or played a part in biofilm formation 
(Saber et al., 2012).  
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Furthermore, since the emergence of NGS, there has been doubt regarding the 
quality of taxonomic identification using short sequencing reads (Kuczynski et 
al., 2012).  This was particularly true with early NGS technologies. However, 
with recent advancement, several of the NGS technologies now offer various 
platforms/options which can sequence various read lengths from 50 bp and up 
to 700 bp, as for 2013 (Di Bella et al., 2013). 
Other common concerns include PCR and primer selection bias, sequencing 
errors and chimera formation and handling and interpretation of the massive 
data that can be produced by bioinformatics especially for human genomic 
studies (Quince et al., 2009; Reeder and Knight, 2009). 
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 General discussion 
 
One of the major shortcomings of cross sectional microbiological studies is that 
they only provide a snapshot at a particular stage. Although this provides some 
information, it is difficult to understand the ecology within that given habitat. 
Nonetheless, a collection of data from various studies may provide a better 
picture. 
Factors that dictate the microbial ecology in a given niche include the local pH, 
abundance and partial pressure of oxygen, redox potential, availability of 
selective nutrients, and the state of local host defences (Marsh and Devine, 
2011). 
Our findings from culture analyses indicated that primary infections were 
dominated by anaerobic species while secondary infections contained 
facultative species. However, from sequencing, it was observed that nine and 
ten of the top 15 genera isolated from primary infections and secondary 
infections, respectively, consisted mostly of anaerobic or facultative anaerobic 
species. It was thought that primary infections are dominated by anaerobic 
species while facultative anaerobes are more prevalent in secondary infections, 
(Baumgartner, 2004; Figdor and Sundqvist, 2007), whereas the more recent 
NGS endodontic studies showed mixed results (Di Bella et al., 2013). 
These conflicting findings may be because different bacterial dominances might 
contribute to different clinical expressions (Li et al., 2010). For instance, 
previous studies comparing chronic and acute root canal infections have 
suggested the latter may contain more species and are associated with 
particular species (Siqueira and Rocas, 2009b; Siqueira et al., 2004).  Similar 
observations were also reported by pyrosequencing (Santos et al., 2011). The 
findings in the present study both in terms of composition and diversity may 
suggest that both primary and secondary infections are associated with unique 
bacterial communities at different stages of the disease. 
Therefore, a better understanding of the ecology and pathogenicity of a 
microbial community requires the thorough knowledge of every component 
involved, including identification of species present at low levels in the 
environment, especially considering that the dental pulp is a previously sterile 
environment (Santos et al., 2011). 
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 Summary and Clinical relevance 
The study produced a number of findings that may have clinical implications. 
 The sequencing analyses demonstrated that both primary and 
secondary infections have a diverse bacterial composition. 
 The biofilm community consists of various species with a dominance of 
facultative anaerobic and obligate anaerobic in particular primary 
infections. 
 A number of bacteria not normally detected in the oral cavity, were 
isolated. 
Some of the clinical implications have already been highlighted earlier and, as 
mentioned, the findings show the importance of previous clinical 
recommendations that are not routinely followed by clinician in day to day 
practice. 
The success of root canal treatment does not only depend on eliminating 
bacteria but also on preventing the introduction of new species. Therefore, the 
adoption of aseptic methods is mandatory in this regard. This may suggest the 
use of an antimicrobial oral rinse before the start of treatment. Tooth surface 
decontamination procedures are normally only used for research purposes to 
avoid false positive samples. It may be beneficial to use these procedures for 
routine cases. The use of an irrigant solution, or preferably a combination of 
irrigant, with full concentration may be recommended. Emphasis should also be 
placed to ensure adequate washing of canals to remove remaining debris. 
Finally, speedy placement of adequate permanent restoration is vital to reduce 
the chances of reinfection. 
 
 Future directions 
First, the study would certainly benefit from a larger sample size. Improvement 
in root canal sampling techniques are necessary in order to provide a better 
representative picture of endodontic microbial community. This, with the 
ongoing advancement in NGS technologies, especially with regards to 
resolution at species level identification, can further refine our knowledge 
regarding the diversity of species as well as their association with different 
clinical conditions. 
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Number Primer Sequence  Tag
1 CAAGCAGAAGACGGCATACGAGATGATTGCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T GATTGC
2 CAAGCAGAAGACGGCATACGAGATGGTAGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T GGTAGT
3 CAAGCAGAAGACGGCATACGAGATGCCAATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T GCCAAT
4 CAAGCAGAAGACGGCATACGAGATTGCACAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TGCACA
5 CAAGCAGAAGACGGCATACGAGATACCACAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T ACCACA
6 CAAGCAGAAGACGGCATACGAGATCCAATCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CCAATC
7 CAAGCAGAAGACGGCATACGAGATTGCAACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TGCAAC
8 CAAGCAGAAGACGGCATACGAGATGAAGGAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T GAAGGA
9 CAAGCAGAAGACGGCATACGAGATCTGAAGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CTGAAG
10 CAAGCAGAAGACGGCATACGAGATTGGCTAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TGGCTA
11 CAAGCAGAAGACGGCATACGAGATAAGGCTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T AAGGCT
12 CAAGCAGAAGACGGCATACGAGATTAGGTCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TAGGTC
13 CAAGCAGAAGACGGCATACGAGATACATGCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T ACATGC
14 CAAGCAGAAGACGGCATACGAGATACGAGAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T ACGAGA
15 CAAGCAGAAGACGGCATACGAGATTGAAGGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TGAAGG
16 CAAGCAGAAGACGGCATACGAGATTCTAGGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TCTAGG
17 CAAGCAGAAGACGGCATACGAGATACCAGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T ACCAGT
18 CAAGCAGAAGACGGCATACGAGATCTTAGGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CTTAGG
19 CAAGCAGAAGACGGCATACGAGATCTGAACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CTGAAC
20 CAAGCAGAAGACGGCATACGAGATGCTTACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T GCTTAC
21 CAAGCAGAAGACGGCATACGAGATTCTGACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TCTGAC
22 CAAGCAGAAGACGGCATACGAGATTGAGTCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TGAGTC
23 CAAGCAGAAGACGGCATACGAGATCACAACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CACAAC
24 CAAGCAGAAGACGGCATACGAGATATCGGTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T ATCGGT
25 CAAGCAGAAGACGGCATACGAGATAGAGCTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T AGAGCT
26 CAAGCAGAAGACGGCATACGAGATATTCGGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T ATTCGG
27 CAAGCAGAAGACGGCATACGAGATTAGGACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TAGGAC
28 CAAGCAGAAGACGGCATACGAGATACCAGAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T ACCAGA
29 CAAGCAGAAGACGGCATACGAGATCATCACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CATCAC
30 CAAGCAGAAGACGGCATACGAGATGTTACCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T GTTACC
31 CAAGCAGAAGACGGCATACGAGATACCATGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T ACCATG
32 CAAGCAGAAGACGGCATACGAGATAACGCTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T AACGCT
33 CAAGCAGAAGACGGCATACGAGATGACTGAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T GACTGA
34 CAAGCAGAAGACGGCATACGAGATCAAGACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CAAGAC
35 CAAGCAGAAGACGGCATACGAGATAGCAAGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T AGCAAG
36 CAAGCAGAAGACGGCATACGAGATTGGACAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T TGGACA
37 CAAGCAGAAGACGGCATACGAGATCTTGTGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CTTGTG
38 CAAGCAGAAGACGGCATACGAGATCTCAAGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T CTCAAG
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Appendix 7: List of all of genera detected  
 Taxonomy 
1 Unassigned 
2 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales 
3 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Actinomycetaceae;g__Actino
myces 
4 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Cellulomonadaceae 
5 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Cellulomonadaceae;g__Actin
otalea 
6 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Cellulomonadaceae;g__Dem
equina 
7 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Corynebacteriaceae;g__Cory
nebacterium 
8 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Microbacteriaceae;Other 
9 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Microbacteriaceae;g__ 
10 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Microbacteriaceae;g__Leuco
bacter 
11 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Micrococcaceae;g__Kocuria 
12 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Micrococcaceae;g__Microco
ccus 
13 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Micrococcaceae;g__Rothia 
14 p__Actinobacteria;c__Actinobacteria;o__Actinomycetales;f__Propionibacteriaceae;g__ 
15 p__Actinobacteria;c__Coriobacteriia;o__Coriobacteriales;f__Coriobacteriaceae;g__ 
16 p__Actinobacteria;c__Coriobacteriia;o__Coriobacteriales;f__Coriobacteriaceae;g__Atopob
ium 
17 p__Actinobacteria;c__Coriobacteriia;o__Coriobacteriales;f__Coriobacteriaceae;g__Slackia 
18 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__;g__ 
19 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__Marinilabiaceae;g__ 
20 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__Porphyromonadaceae;g__ 
21 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__Porphyromonadaceae;g__Dysgono
monas 
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22 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__Porphyromonadaceae;g__Paludiba
cter 
23 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__Porphyromonadaceae;g__Parabact
eroides 
24 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__Porphyromonadaceae;g__Porphyro
monas 
25 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__Prevotellaceae;g__Prevotella 
26 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__RF16;g__ 
27 p__Bacteroidetes;c__Bacteroidia;o__Bacteroidales;f__Rikenellaceae;g__Blvii28 
28 p__Bacteroidetes;c__Cytophagia;o__Cytophagales;f__Cyclobacteriaceae;g__ 
29 p__Bacteroidetes;c__Cytophagia;o__Cytophagales;f__Cytophagaceae;g__ 
30 p__Bacteroidetes;c__Cytophagia;o__Cytophagales;f__Cytophagaceae;g__Dyadobacter 
31 ;p__Bacteroidetes;c__Cytophagia;o__Cytophagales;f__Flammeovirgaceae;g__ 
32 p__Bacteroidetes;c__Flavobacteriia;o__Flavobacteriales;f__Cryomorphaceae;Other 
33 p__Bacteroidetes;c__Flavobacteriia;o__Flavobacteriales;f__Cryomorphaceae;g__ 
34 p__Bacteroidetes;c__Flavobacteriia;o__Flavobacteriales;f__Cryomorphaceae;g__Fluviicol
a 
35 p__Bacteroidetes;c__Flavobacteriia;o__Flavobacteriales;f__Flavobacteriaceae;Other 
36 p__Bacteroidetes;c__Flavobacteriia;o__Flavobacteriales;f__Flavobacteriaceae;g__Capno
cytophaga 
37 p__Bacteroidetes;c__Flavobacteriia;o__Flavobacteriales;f__Flavobacteriaceae;g__Flavob
acterium 
38 p__Bacteroidetes;c__Flavobacteriia;o__Flavobacteriales;f__[Weeksellaceae];g__ 
39 p__Bacteroidetes;c__Flavobacteriia;o__Flavobacteriales;f__[Weeksellaceae];g__Chryseo
bacterium 
40 p__Bacteroidetes;c__Sphingobacteriia;o__Sphingobacteriales;f__;g__ 
41 p__Chloroflexi;c__Anaerolineae;o__S0208;f__;g__ 
42 p__Chloroflexi;c__Anaerolineae;o__SBR1031;f__A4b;g__ 
43 p__Chloroflexi;c__Thermomicrobia;o__JG30-KF-CM45;f__;g__ 
44 p__Cyanobacteria;c__ML635J-21;o__;f__;g__ 
45 p__Firmicutes;c__Bacilli;Other;Other;Other 
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46 p__Firmicutes;c__Bacilli;o__Bacillales;Other;Other 
47 p__Firmicutes;c__Bacilli;o__Bacillales;f__;g__ 
48 p__Firmicutes;c__Bacilli;o__Bacillales;f__Bacillaceae;Other 
49 p__Firmicutes;c__Bacilli;o__Bacillales;f__Bacillaceae;g__ 
50 p__Firmicutes;c__Bacilli;o__Bacillales;f__Bacillaceae;g__Anaerobacillus 
51 p__Firmicutes;c__Bacilli;o__Bacillales;f__Bacillaceae;g__Bacillus 
52 p__Firmicutes;c__Bacilli;o__Bacillales;f__Paenibacillaceae;g__Paenibacillus 
53 p__Firmicutes;c__Bacilli;o__Bacillales;f__Staphylococcaceae;g__Staphylococcus 
54 p__Firmicutes;c__Bacilli;o__Bacillales;f__[Exiguobacteraceae];g__ 
55 p__Firmicutes;c__Bacilli;o__Bacillales;f__[Exiguobacteraceae];g__Exiguobacterium 
56 p__Firmicutes;c__Bacilli;o__Lactobacillales;Other;Other 
57 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__;g__ 
58 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Aerococcaceae;Other 
59 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Aerococcaceae;g__Aerococcus 
60 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Aerococcaceae;g__Alkalibacterium 
61 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Aerococcaceae;g__Marinilactibacillus 
62 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Carnobacteriaceae;g__Granulicatella 
63 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Enterococcaceae;Other 
64 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Enterococcaceae;g__ 
65 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Enterococcaceae;g__Enterococcus 
66 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Lactobacillaceae;g__ 
67 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Lactobacillaceae;g__Lactobacillus 
68 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Lactobacillaceae;g__Pediococcus 
69 p__Firmicutes;c__Bacilli;o__Lactobacillales;f__Streptococcaceae;g__Streptococcus 
70 p__Firmicutes;c__Clostridia;o__Clostridiales;Other;Other 
71 p__Firmicutes;c__Clostridia;o__Clostridiales;f__;g__ 
72 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Clostridiaceae;Other 
73 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Clostridiaceae;g__ 
74 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Clostridiaceae;g__Alkaliphilus 
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75 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Clostridiaceae;g__Clostridium 
76 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Clostridiaceae;g__Geosporobacter_Ther
motalea 
77 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Eubacteriaceae;g__Pseudoramibacter_Eu
bacterium 
78 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Lachnospiraceae;Other 
79 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Lachnospiraceae;g__ 
80 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Lachnospiraceae;g__Coprococcus 
81 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Lachnospiraceae;g__Epulopiscium 
82 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Lachnospiraceae;g__Moryella 
83 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Lachnospiraceae;g__Oribacterium 
84 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Peptococcaceae;g__ 
85 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Peptostreptococcaceae;g__ 
86 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Peptostreptococcaceae;g__Peptostreptoc
occus 
87 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Ruminococcaceae;g__ 
88 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Veillonellaceae;g__ 
89 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Veillonellaceae;g__Acidaminococcus 
90 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Veillonellaceae;g__Megasphaera 
91 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Veillonellaceae;g__Schwartzia 
92 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Veillonellaceae;g__Selenomonas 
93 p__Firmicutes;c__Clostridia;o__Clostridiales;f__Veillonellaceae;g__Veillonella 
94 p__Firmicutes;c__Clostridia;o__Clostridiales;f__[Acidaminobacteraceae];g__Fusibacter 
95 p__Firmicutes;c__Clostridia;o__Clostridiales;f__[Mogibacteriaceae];g__ 
96 p__Firmicutes;c__Clostridia;o__Clostridiales;f__[Mogibacteriaceae];g__Mogibacterium 
97 p__Firmicutes;c__Clostridia;o__Clostridiales;f__[Tissierellaceae];g__Parvimonas 
98 p__Fusobacteria;c__Fusobacteriia;o__Fusobacteriales;f__Fusobacteriaceae;g__Fusobact
erium 
99 p__Fusobacteria;c__Fusobacteriia;o__Fusobacteriales;f__Leptotrichiaceae;g__Leptotrichi
a 
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100 p__Proteobacteria;c__Alphaproteobacteria;o__Rhizobiales;f__Beijerinckiaceae;g__ 
101 p__Proteobacteria;c__Alphaproteobacteria;o__Rhizobiales;f__Hyphomicrobiaceae;g__De
vosia 
102 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodobacterales;f__Rhodobacteraceae;Ot
her 
103 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodobacterales;f__Rhodobacteraceae;g_
_ 
104 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodobacterales;f__Rhodobacteraceae;g_
_Anaerospora 
105 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodobacterales;f__Rhodobacteraceae;g_
_Loktanella 
106 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodobacterales;f__Rhodobacteraceae;g_
_Paracoccus 
107 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodobacterales;f__Rhodobacteraceae;g_
_Rhodobaca 
108 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodobacterales;f__Rhodobacteraceae;g_
_Rhodobacter 
109 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodospirillales;f__Acetobacteraceae;g__ 
110 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodospirillales;f__Acetobacteraceae;g__
Roseococcus 
111 p__Proteobacteria;c__Alphaproteobacteria;o__Rhodospirillales;f__Rhodospirillaceae;g__ 
112 p__Proteobacteria;c__Betaproteobacteria;o__Burkholderiales;f__Burkholderiaceae;g__La
utropia 
113 p__Proteobacteria;c__Betaproteobacteria;o__Burkholderiales;f__Comamonadaceae;Other 
114 p__Proteobacteria;c__Betaproteobacteria;o__Burkholderiales;f__Comamonadaceae;g__ 
115 p__Proteobacteria;c__Betaproteobacteria;o__Burkholderiales;f__Comamonadaceae;g__D
elftia 
116 p__Proteobacteria;c__Betaproteobacteria;o__Burkholderiales;f__Comamonadaceae;g__H
ydrogenophaga 
117 p__Proteobacteria;c__Betaproteobacteria;o__Burkholderiales;f__Comamonadaceae;g__V
ariovorax 
118 p__Proteobacteria;c__Betaproteobacteria;o__Burkholderiales;f__Oxalobacteraceae;g__ 
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119 p__Proteobacteria;c__Betaproteobacteria;o__Neisseriales;f__Neisseriaceae;g__Kingella 
120 p__Proteobacteria;c__Betaproteobacteria;o__Neisseriales;f__Neisseriaceae;g__Neisseria 
121 p__Proteobacteria;c__Deltaproteobacteria;o__Desulfovibrionales;f__Desulfovibrionaceae;
g__Desulfovibrio 
122 p__Proteobacteria;c__Epsilonproteobacteria;o__Campylobacterales;f__Campylobacterace
ae;g__Campylobacter 
123 p__Proteobacteria;c__Gammaproteobacteria;o__Alteromonadales;f__[Chromatiaceae];Ot
her 
124 p__Proteobacteria;c__Gammaproteobacteria;o__Alteromonadales;f__[Chromatiaceae];g_
_Alishewanella 
125 p__Proteobacteria;c__Gammaproteobacteria;o__Alteromonadales;f__[Chromatiaceae];g_
_Alkalimonas 
126 p__Proteobacteria;c__Gammaproteobacteria;o__Alteromonadales;f__[Chromatiaceae];g_
_Rheinheimera 
127 p__Proteobacteria;c__Gammaproteobacteria;o__Cardiobacteriales;f__Cardiobacteriaceae
;g__Cardiobacterium 
128 p__Proteobacteria;c__Gammaproteobacteria;o__Enterobacteriales;f__Enterobacteriaceae
;g__ 
129 p__Proteobacteria;c__Gammaproteobacteria;o__Legionellales;f__Coxiellaceae;g__ 
130 p__Proteobacteria;c__Gammaproteobacteria;o__Oceanospirillales;f__Halomonadaceae;g
__Candidatus Portiera 
131 p__Proteobacteria;c__Gammaproteobacteria;o__Oceanospirillales;f__Halomonadaceae;g
__Halomonas 
132 p__Proteobacteria;c__Gammaproteobacteria;o__Oceanospirillales;f__Oceanospirillaceae;
g__Nitrincola 
133 p__Proteobacteria;c__Gammaproteobacteria;o__Pasteurellales;f__Pasteurellaceae;g__H
aemophilus 
134 p__Proteobacteria;c__Gammaproteobacteria;o__Pseudomonadales;f__Moraxellaceae;g_
_Acinetobacter 
135 p__Proteobacteria;c__Gammaproteobacteria;o__Pseudomonadales;f__Pseudomonadace
ae;Other 
136 p__Proteobacteria;c__Gammaproteobacteria;o__Pseudomonadales;f__Pseudomonadace
ae;g__ 
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137 p__Proteobacteria;c__Gammaproteobacteria;o__Pseudomonadales;f__Pseudomonadace
ae;g__Pseudomonas 
138 p__Proteobacteria;c__Gammaproteobacteria;o__Xanthomonadales;f__Xanthomonadacea
e;g__Aquimonas 
139 p__Proteobacteria;c__Gammaproteobacteria;o__Xanthomonadales;f__Xanthomonadacea
e;g__Stenotrophomonas 
140 p__Spirochaetes;c__Spirochaetes;o__Spirochaetales;f__Spirochaetaceae;g__Treponema 
141 p__Synergistetes;c__Synergistia;o__Synergistales;f__Dethiosulfovibrionaceae;g__TG5 
142 p__TM7;c__TM7-1 
143 p__TM7;c__TM7-3 
144 p__TM7;c__TM7-3;o__EW055 
 
 
